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Abstract
Previous studies have found that addition of osmolytes weakens the binding of
dihydrofolate (DHF) to R67 dihydrofolate reductase (DHFR), chromosomal DHFR from E. coli
and a pteridine reductase. These results support the preferential interaction of DHF with osmolytes
compared to water. Thus, a working model where interaction of DHF with osmolytes shifts the
binding away from the protein-DHF complex towards the free species was proposed. As
tetrahydrofolate and other folate redox states have similar structures to DHF, we predict osmotic
stress will lower the catalytic efficiencies of other folate pathway enzymes. In this thesis, we
explore the in vivo effects of increasing osmolality on the activity of folate pathway enzymes.
Essential folate enzymes were selected and the genes cloned into a tunable plasmid (pKTS) with
a tetracycline promoter (Ptet) and a SsrA degradation tag. The appropriate clone was transformed
into a knockout strain of E. coli followed by optimization of the in vivo protein concentration with
tetracycline dependent cell growth. Then, the intracellular osmolality of the knockout E. coli strain
was increased by adding sorbitol to the growth media. Finally, the effects of increasing osmolality
on the function of the clone were determined by comparing the cell growth between the control
and test plates.
Our in vivo assays showed R67 DHFR rescued DH5 E. coli from trimethoprim pressure
as well as E. coli LH18 (delta fol::kan) from folate end product auxotrophy. Growth of test cells
on minimal media was blocked at a lower osmolality compared to growth of a positive control on
supplemented media. These results demonstrate a proof of concept that our assay conditions
evaluated the in vivo activity of R67 DHFR and found it to be sensitive to osmotic stress.
The genes for two other folate pathway enzymes, methylene tetrahydrofolate reductase and
serine hydroxymethyl transferase, were cloned into the pKTS vector. Their ability to respond to
in vivo osmotic pressure can now be performed.
Finally, the ability of a strain carrying a mutant folylpolyglutamate synthase gene to
withstand osmotic stress was explored. The results were limited by the strain’s lower sensitivity
to osmolality, thus further experiments need to be performed.
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Chapter 1: Introduction
1

Introduction
Folate is also known as vitamin B9 and its structure is composed of pterin, p-

aminobenzoate (pABA), and glutamate moieties Figure 1-1 (below) [6]). These molecules are
essential for life. Humans and higher animals cannot synthesize folate, thus they obtain folate
from their diet. Plants and bacteria synthesize folate de novo. In all domains of life, folates are
required for several cellular processes such as DNA, RNA, purine nucleotide, and amino acid
synthesis. In the folate pathway, tetrahydrofolate (THF) is the active species as it can carry methyl
or formyl groups on either its N5 and/or N10 position(s). These molecules are one carbon carriers
that lead to synthesis of thymidylate, serine, methionine, etc.

Figure 1-1: Folate contains pterin, pABA and glutamate moieties.
Tetrahydrofolate, shown above, plays a role in the folate pathway by adding carbons at the N5
(R) and/or N10 (X) position(s) [6]
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1.1

Osmolyte interaction with DHF/folate affects the activity of three DHFR enzymes
The Howell lab has studied the structure-function relationship in dihydrofolate reductase

(DHFR). Recent studies have focused on examining the role of water on folate/DHF and/or
cofactor binding. One way of examining the activity of water in binding is to perturb the water
molecules in the hydration shell of the interacting molecules (for example, protein plus ligand) by
the gradual increase of osmolyte (co-solvent) concentrations and monitoring the change in
catalytic efficiency and/or binding. A typical result is tighter binding of a ligand to protein as fewer
water molecules need to be removed and the desolvation penalty is decreased. Another case is
provided if the affinity of the protein surface is greater for osmolytes compared to the water
molecules, then the osmolytes compete with water and weakly interact with the protein surface. A
cartoon representation of preferential interaction and preferential exclusion of osmolytes from a
protein surface is presented in Figure 1-2 (below) If osmolytes are more difficult to remove than
water, then the binding equilibrium will be shifted towards the free state, which will weaken
binding. Thus, Chopra et al. studied the role of water on binding in the primitive enzyme, R67
DHFR [1].

Figure 1-2 Models of preferential exclusion and preferential interaction
The solvation layer of the enzyme is shown in light grey, while the bulk solvent is dark grey.
Osmolytes are represented by white ovals [7]. Panel A shows preferential exclusion while
Panel B shows preferential interaction of osmolytes with the protein surface.
The binding of NADPH to apo R67 DHFR was investigated using isothermal titration
calorimetry (ITC). Tighter binding was observed upon the addition of ethylene glycol, sucrose,
dimethyl sulfoxide (Me2SO), glycine betaine, or PEG400 as shown in
2

Figure 1-3 Plot of ln Ka versus osmolality (below/right) [1]. This result is the typical observation
associated with osmotic stress studies as a lower water concentration leads to a decreased
desolvation barrier associated with binding. All osmolytes tested have the same effect, consistent
with exclusion of the osmolytes from the surfaces of NADPH and R67 DHFR [1].

Figure 1-3 Plot of ln Ka versus osmolality
The Ka for DHF binding to R67 DHFR-NADP+ was determined by ITC. Weaker binding and
sensitivity to osmolyte identity was observed (left). In contrast, the Ka for NADPH binding to
apo R67 DHFR showed a single positive slope (right). These two plots possess opposite slopes.
The results for DHF are consistent with a preferential interaction model while the results for
NADPH are consistent with a preferential exclusion model. Data for buffer (gray circle),
ethylene glycol (open circle), sucrose (open square), Me2SO(open circle), glycine betaine (open
triangle), and PEG400 (checkerboard) are shown. Adopted from [1].
When reduction of DHF was investigated using steady state kinetics, the catalytic rate
constant, kcat, showed minimal to no variation. However, a significant increase in KM(DHF) values
was observed.

These combined behaviors result in a decrease in catalytic efficiency or

kcat/KM(DHF). If KM equals Kd, this result suggests the drop in catalytic efficiency is due to weaker
binding of DHF [1].

3

Figure 1-4 A plot of osmolality versus ln kcat/Km (DHF) for R67 DHFR.
Steady state kinetic data were obtained at saturating NADPH concentration and varied DHF
concentrations in the presence of various osmolytes. Michaelis-Menten plots were used to
calculate kcat and Km (DHF) values. The units for kcat/KM (DHF) are s-1 M-1. Adopted from [1].
Next, to directly monitor the Kd associated with DHF binding, Chopra et al. titrated DHF
into R67 DHFR-NADP+ in the presence of increasing concentrations of sucrose, glycine betaine
or PEG400 [1]. Their results showed a steady decline in ln Ka as the osmolyte concentration
increased. The use of PEG400 showed a steeper negative slope in the plot Figure 1-3 (above left )
which correlates with its also acting as a crowding agent due to its larger volume [1].
As R67 DHFR possesses 222 symmetry and a single active site pore to bind its ligands,
this results in the same site being able to accommodate either cofactor or DHF [8]. This unusual
active site allows the Howell lab to use osmotic stress results for NADPH as an internal control,
which indicates no osmolyte interaction with either NADPH or R67 DHFR. If osmolytes don’t
interact with R67 DHFR, the likely reason for weaker binding of DHF is a preferential interaction
of osmolytes with DHF. This hypothesis led to the cartoon shown in Figure 1-5 (below).

4

Figure 1-5 Model showing the preferential interaction of osmolytes with free DHF.
Removal of water (★) and/or osmolytes (red star) from the solvation shell of DHF is required
for the ligand to bind to DHFR. If the DHF-osmolyte association is stronger than the
DHF−water interaction, the binding equilibrium will be shifted to the left, favoring the
unbound state. This results in a decreased binding affinity of DHF for DHFR. This model does
not exclude interactions between osmolytes and the protein. Adopted from [3].
The model of folate/DHF interaction with osmolytes was tested using two additional folate
enzymes, chromosomal DHFR from E. coli (EcDHFR) [2] and FolM [3]. These enzymes catalyze
the DHFR reaction, but they have dissimilar sequences, structures and oligomerization states [3].
For both enzymes studied by steady state kinetics and/or ITC, the KM for DHF increased and/or
the Ka decreased [2, 3]. These results are consistent with the model.

1.2

Osmoprotectants: natural organic solutes generated to rescue cells from osmotic stress.
Osmolytes are low molecular mass compounds. These molecules are compatible or

noncompatible with macromolecules. Compatible osmolytes destabilize both the native and
unfolded states by their exclusion from the peptide backbone; however, the unfolded state is more
affected, resulting in a larger energy difference between the native and unfolded states. This leads
to protein folding ([9]). Noncompatable osmolytes interact more strongly with the unfolded form
of the protein which destabilizes it [10]. Based on their chemical composition, osmolytes are
divided into three classes: polyhydric alcohols and sugars (polyols), amino acids and their
derivatives, and methyl ammonium compounds (see Figure 1-6 (below) [11]). Bacteria and plants
generate small organic solutes (osmolytes) or transport them from the environment into the cell to
5

maintain the osmolality of the cell upon external osmotic stress. The internal osmolytes help to
compensate for cell volume changes, by stabilizing macromolecules [12] and/or by aiding protein
folding [13].

Figure 1-6 Chemical structures of selected naturally occurring osmolytes.
Gray shows carbon atoms, red shows oxygen, blue shows nitrogen and yellow shows sulfur.
Adopted from [11].
The chemical properties and sizes of osmolytes can be correlated with the number of water
molecules (∆nw) excluded from the hydration shell of proteins [13, 14]. The Record group has
provided two excellent reviews of osmoprotectants in bacteria [15, 16]. In the intracellular
bacterial environment, the total cytoplasmic water content is the sum of ‘bound’ and ‘free/bulk’
water. Typically the ‘bound’ water molecules are not affected by osmotic stress i.e. the organism
does not lose bound water but rather ‘free’ water molecules [17]. In normal circumstances, ‘free’
water molecules move in and out of the cell. However, if there is a difference in osmotic strength
between the internal and external environments, the bacteria face sudden free water loss and can
shrink. To overcome this situation, the bacteria produce intracellular osmolytes to balance the
osmolality of the internal environment with that of the outside environment. Thus the intracellular
osmolyte(s) concentration increases [17]. Common osmoprotectants in E. coli are glycine betaine,
glutamate, proline and trehalose.
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1.3

Probing how water activity affects R67 DHFR binding in vivo
As betaine is a common osmoprotectant in E. coli and as betaine decreases, the catalytic

efficiency of R67 DHFR (see Figure 1-4 (above)), Chopra et al. examined the effect of osmotic
stress on R67 DHFR function in vivo [1]. Both EcDHFR and R67 DHFR reduce folate/DHF to
THF, however the chromosomal DHFR is easily inhibited by addition of the antibacterial drug
trimethoprim (TMP, Ki = 20 pM) [18]. In contrast, TMP does not inhibit R67 DHFR very well (Ki
= 0.15 mM) [19]. Thus, the activity of chromosomal enzyme was inhibited by addition of 20 µg
TMP/ml [20]. Then osmotic stress was applied to the host cell by adding sorbitol to a minimal
growth media. The ability of E. coli DH5α carrying wild type or mutant (Q67H, K32M, or Y69L)
R67 DHFR genes cloned in pUC8 was then assessed [1].
The wild type and the Q67H and Y69L mutant clones rescued the host cells from TMP
pressure, but the Y69L mutant clone required an extended growth time [1]. These results
correlated with the activity of the type of R67 DHFR variant. For example, the host cell carrying
the wild type R67 DHFR clone had sufficient enzyme activity to reduce DHF to THF and could
enable cell growth. However, host cells carrying the Y69L mutant clone had a lower catalytic
efficiency and took a longer time to allow host cell growth. On the other hand, the K32M R67
DHFR clone did not rescue its host cell, suggesting the mutant enzyme did not possess sufficient
DHFR activity to rescue the cell from trimethoprim pressure [21].
In the next set of assays, increasing concentrations of sorbitol were added. E. coli DH5α
carrying the wt R67 DHFR-pUC8 clone allowed cell growth in the presence of TMP until the
osmolality of the media became ≥ 1.95 Osm. As per the Record lab, this result suggests that the
host cell stops growing due to loss of free water in the cytoplasm [17]. In contrast, E. coli DH5α
carrying the mutant Y69L R67 DHFR-pUC8 clone grew very slowly and stopped growing under
much less osmotic stress (0.92 Osm). This result was interpreted as the lower activity associated
with the Y69L R67 DHFR clone was less able to rescue the host cell; thus its activity could be
titrated by osmotic stress. This titration follows the loss of enzyme activity upon osmolyte addition
as seen in Figure 1-4 (above).
Titration of the activity of the wt R67 DHFR clone by sorbitol addition was not observed
in the above experiments. Since the maximal activity (Vmax) of an enzyme can be described as
kcat* [Etotal], where [Etotal] describes the total enzyme concentration, these two parameters need to
be considered. The wt enzyme is reasonably active with a kcat/Km of 2.2 x 105 M-1 s-1. In addition,
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the protein is overexpressed due to the high copy number of the pUC8 plasmid. A similar problem
of in vivo assay for a metabolically essential enzyme with high protein production, but poor
enzymatic activity was previously described by the Hilvert lab [22].
1.4

Rationale for a genetic approach
Vapor pressure osmometry studies by the Record group have monitored the interaction of

betaine, proline and urea with various small molecules [23-25]. From these studies, they have
derived atomistic preferential interaction coefficients (23/RT) which allow prediction of whether
water or betaine/proline/urea prefers to interact with larger molecules. A positive value indicates
exclusion of osmolyte from the molecule; for example, glutamate, phosphate and citrate all exclude
betaine from their carboxylate and phosphate atoms. A high 23/RT value is 1.2. A value of zero
for 23/RT indicates no preference for water vs betaine. A negative value indicates a preference
for the molecule to interact with betaine. Capp et al. find a 23/RT value of -0.091 for the
interaction of benzoate with betaine [1]. The Howell lab has used this approach in predicting the
interaction of betaine with folate and DHF. The predicted values are in the ballpark of the
experimentally measured values, suggesting this approach is reasonable (predicted 23/RT values
are shown in Table 1-1 (below). As tetrahydrofolate and its various derivatives possess very similar
structures to folate, our prediction is that betaine will also interact with these redox states of folate
[23-25].
To test this prediction, we can purify the relevant enzymes and do in vitro osmotic pressure
studies. As purifying enzymes and doing in vitro osmotic stress studies is quite time-consuming,
our hope is that a genetic approach will be faster. This approach will also test whether our model
in Figure 1-5 (above) continues to work in the crowded environment of the cell with many other
molecules and macromolecules present.
As the growth of various E. coli strains is not titrated by increasing concentrations of
sorbitol (except for the limit when no free water remains as per Cayley et al. [17]), we need a
system that will decrease the total enzyme activity in the cell for folate pathway enzymes. Since
a single gene exists per E. coli chromosome, a system is needed that will produce less active protein
than normally exists per E. coli cell. For this type of system, we plan on transforming selected
Keio deletant strains [26] with a plasmid that controls gene expression and protein stability.
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Table 1-1 Values of predicted µ23/RT: interaction of folate species with betaine.
µ23/RT values were calculated according to Capp et al. [23] and are listed below. These values
predict the potential interaction preference of betaine with various reduced forms of folate
molecules with 0, 1, 2 or 3 glutamates in their tails. As betaine is excluded from glutamate, addition
of extra glutamates to the folate molecule results in increases in the predicted value.
Betaine µ23/RT

a

Folate Species

(glu)0

(glu)1

(glu)2

(glu)3

5-formyl-tetrahydrofolate

n/aa

0.228

0.579

0.893

5-methyl-tetrahydrofolate

n/aa

0.146

0.493

0.806

6-hydroxymethyldihydropterin

-0.024

n/aa

n/aa

n/aa

10-formyl-tetrahydrofolate

n/aa

0.287

0.623

0.937

10-methyl-tetrahydrofolate

n/aa

0.176

0.524

0.837

6-hydroxymethyl-7,8-dihydropterin pyrophosphate

0.907

n/aa

n/aa

n/aa

Dihydropteroate

-0.166

n/aa

n/aa

n/aa

N5-N10- methenyl-tetrahydrofolate

n/aa

0.167

0.512

0.829

N5-N10-methylene-tetrahydrofolate

n/aa

0.163

0.509

0.826

p-aminobenzoate

-0.122

0.168

0.47

0.718

Tetrahydropteroate

-0.162

n/aa

n/aa

n/aa

Tetrahydrofolate

n/aa

0.133

0.479

0.791

Dihydrofolate

n/aa

0.128

0.523

0.766

Folate

n/aa

-0.039

0.359

0.685

Glutamate

n/aa

0.451

0.744

1.095

Citrate

0.683

n/aa

n/aa

n/aa

Phosphate

0.986

n/aa

n/aa

n/aa

Diphosphate

1.294

n/aa

n/aa

n/aa

Not applicable

1.5

Decreasing the protein concentration and/or enzyme rate improves the total in vivo activity
As described by the Hilvert lab, the in vivo selection of a chorismate mutase clone with a

high protein production, but poor enzymatic activity could be improved by minimizing the protein
production level (see Figure 1-7 (below) [22]). To address this problem in our system, we will use
the pKTS plasmid obtained from the Hilvert lab [4]. The pKTS vector has two ways to control
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protein production: use of the Ptet promoter and introduction of a protease degradation tag (SsrA)
(see Figure 1-8 and Figure 1-9 (below) [4]. In this vector, the gene of interest is cloned between
the tetracycline promoter (Ptet) and a sequence encoding a SsrA tag. The Ptet promoter has a large
regulatory window. At the lowest tetracycline concentration, it allows basal expression of a gene
to the tune of one mRNA molecule per three cells [27]. In addition, use of a SsrA tag (AANDENYALA) on the C-terminus of the protein, directs the protein to the ClpX protease for
degradation [4]. This approach may sufficiently minimize the protein production as to allow
titration of enzyme activity by a decreased water activity see Figure 1-7 (below).

Figure 1-7 Effects of total enzyme activity on cell growth rate.
The best selection window is at the center of the graph. The left hand side of the graph
describes conditions where the total enzyme activity is too low to enable growth. The right
hand side of the graph describes conditions where selection is not possible due to high
expression levels or high activity of the enzyme. Titration of enzyme activity is possible when
either a low protein concentration or a low enzyme activity (due to mutation) occurs; the black
curve represents the low protein production or enzyme activity, the red curve represents
medium protein production where selection is possible, and the blue color represents high
protein production where in vivo selection is problematic. Adapted from [22].
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Figure 1-8 Map of the tunable vector pKTS
The gene of interest (for example, R67 DHFR) is cloned into the pKTS vector obtained from
the Hilvert lab. In this vector, transcription of the R67 DHFR gene is controlled by the
tetracycline repressor (TetR) and tetracycline promoter (Ptet). Therefore, while Tc exerted its
antibiotic activity in the system, transcription of TetR promotes Tc resistance [28]. As a result,
only the basal level of the promoter activity that correlates with the Tc concentration is allowed
[29]. In addition to the TetR and Ptet system, the SsrA tag at the C- terminal sequence
destabilizes the gene product and directs the protein to the ClpX protease for degradation.
Adopted from [4]

Figure 1-9 pKTS : selection strategies, controlling the intracellular concentration of “X”
The gene of interest, ‘X’, is cloned between the PtetA promoter and a sequence encoding a SsrA
tag. The pKTS plasmid permits transcriptional control and limits enzyme half-life. The SsrA
sequence is fused to the C-terminus of the protein of interest. Minimizing protein production
should allow an in vivo selection of folate pathway enzyme activity [4].
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1.6

Folate enzyme selection criteria for in vivo osmotic stress studies
To select candidate enzymes in the folate cycle for these studies, we used the following

three criteria. First, the enzyme must be essential and/or selectable; Table 1-2 (below) lists various
genes in the folate pathway and notes whether they are essential (Bold/underlined). Second, the Cterminus and/or N-terminus should not be in a close proximity to the active site as this would block
our ability to use the pKTS vector or the pKTR vector (which puts a RepA degradation tag on the
N-terminus) to control protein expression levels. And third, we prefer the KM of the folate derived
substrate to be higher than the respective substrate concentration in the cell. We discuss these
issues below.
Essential enzymes are required for the survival of a cell. For example, DHFR is essential
for synthesis of thymidylate, methionine, glycine, serine and purines in bacteria. Therefore, it was
possible to assay the effect of increasing external osmotic stress via a gradual decline in cell
growth. We aimed to use a similar approach with other enzymes in the folate mediated one carbon
(1C) cycle. As noted in Table 1-2 (below), there are many essential folate cycle enzymes.
Secondly, since we aimed to use the pKTS plasmid, we were concerned whether the SsrA tag
could have an effect on enzyme activity. Therefore, we measured the closest distance between
the active site of the selected enzymes and their C-terminus using the Molecular Operating
Environment computer program (MOE), version 2012.10 [30]. If the C-terminus is very close to
the active site, we could use an alternative vector, pKTR, that adds an N-terminal RepA
degradation tag [22]. The distance range between the active site and the C-terminus is listed in
Table 1-3 (below). This table also lists whether the C-terminus has been previously tagged to aid
in purification. For example, if a histag is tolerated, this supports the feasibility of adding a SsrA
tag. We also note that if fusion with a SsrA tag impairs enzyme activity, this might be acceptable
as we need to have low total activity levels to titrate enzyme activity in vivo.
Lastly, if the substrate concentration of the folate metabolite in the cell is much higher than
the KM, the active site of the enzyme would be saturated. Thus, it could be difficult to observe
measurable effects induced by osmotic stress. To avoid this potential problem, the concentrations
of metabolites in vivo were identified based on previously published E. coli K12 metabolite
concentrations [31] and compared to literature KM values.
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1.7

Selected folate cycle enzymes
We considered the following enzymes: Dihydropteroate Synthase (DHPS encoded by the

folP gene); Folylpolyglutamate Synthase (FPGS encoded by the folC gene); R67 dihydrofolate
reductase (a type II DHFR that provides resistance to the antibacterial drug trimethoprim); Serine
Hydroxymethyl Transferase (SHMT encoded by glyA); Methylenetetrahydrofolate Reductase
(MTHFR encoded by metF); and Thymidylate Synthase (TS encoded by thyA) Figure 1-10
(below):

Table 1-2: Folate mediated one-carbon metabolism genes that are essential in E. coli
Gene

Enzyme (Abbreviation)

Essential/ Non-essential

folA

Dihydrofolate reductase (EcDHFR)

Yes [21, 26]

folB

Dihydroneopterin aldolase

No

folC

Folylpolyglutamate synthase (FPGS)

Yes [21]

folD

Bifunctional methylene tetrahydrofolate
reductase/cyclohydrolase

Yes [21]

folE

GTP cyclohydrolase I

Yes [21, 26]

folK

Yes [21, 26]

folM

2-amino-4-hydroxy-6-hydroxymethyl-dihydropteridine
pyrophosphokinase (HPPK)
Pteridine Reductase (FolM)

folP

Dihydropteroate Synthase (DHPS)

Uncertain [27]

glyA

Serine Hydroxymethyltransferase (SHMT)

No [21], Yes [26]

metF

Methylenetetrahydrofolate Reductase (MTHFR)

No [21]

purU

Formyl-tetrahydrofolate Deformylase

Yes [26]

thyA

Thymidylate Synthase (TS)

No [21], Yes [26]

No [21]

Bold/underlined: enzymes selected for in vivo osmolality study are in Bold/Underline.
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Table 1-3 List of selected enzymes & distance between the C-terminus and the active site.
Selected folate pathway enzymes are listed along with their PDB file names, oligomerization
states, ligands bound in the crystal structure, distances between the active site and the C-terminus
and information on whether the protein has been expressed with a histag, GST fusion or other.
Protein (PDB)

Oligomeric
state

Bound ligands

R67 DHFR
(1VIE)[8]

Homotetram
er

NADP+

≥19 Ǻ

E. coli enzyme expressed
with a C-terminal histag [32]

Quad4 (n/a)

Monomer

n/ab

n/ab

MTHFR
(1ZPT)
[33]

Tetramer

≥ 25 Å

FPGS
(1W78)
[35]

Monomer

SHMT
(1DFO)
[37]

Dimer

DHPS
(1AJOP)
[39]

Monomer

HPPK
(3KUH)

Monomer

TS (1AXW)

Dimer

Sulfate ion, flavinadenine dinucleuotide,
1,4-dihydronicotinamide
adenine dinucleotide,
NADH
Lysine NZ-carboxylic
acid, magnesium ion,
sulfate ion,
phosphorylated
dihydropteroate,
adenosine-5’-diphosphate
N-Glycine-[3-hydroxy-2methyl-5
phosphonooxymethylpyridin-4-yl-methane], 5Formyl-tetrahydrofolate,
N-pyridoxyl-glycine-5monophosphate
Sulfanilamide, sulfate
ion, 2-amino-6hydroxymethyl-7,8dihydro-3H-pteridin- 4one
Diphosphomethylphosphonic acid adenosyl
ester, 2-amino-6hydroxymethyl-7, 8-dihydro-3h-pteridin-4one, magnesium ion,
chloride ion, acetate ion
Methotrexate and dUMP

E. coli enzyme expressed
with a C-terminal histag [5]
E. coli enzyme expressed
with a C-terminal histag [34]

a

Distance

Histag or other fusion?

≥ 26Å

E. coli enzyme expressed
with a histag, however not
stated whether tag is at N- or
C-terminus [36]

≥ 25Å

Strep tagged C-terminus for
SHMT from Chlamydia
pneumonia [38]

≥ 22Å

DHPS from Plasmodium
falciparum tolerates a Cterminal GST tail [40]

≥9Å

HPPK and DHPS from
Francisella tularensis exist as
a bifunctional HPPK-DHPS
fusion [41] ; HPPK from E.
coli tolerates a C-terminal
GST fusion[42]

<7 Åc

Distance between active site and C-terminus
Crystal structure is not available
c
N-formyl-methionine at N-terminus forms H-bonds with T46 and T47
b
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Figure 1-10 Simplified Model of Folate Cycle : Selected enzymes shown with arrows.
The folP gene (purple arrow) encodes dihydropteroate synthase or DHPS and this protein
forms 7,8-dihydropteroate or H2-pteroate from 7,8-dihydropterin-methyl diphosphate
(H2MPt-P2) and p-amino benzoic acid. The folC gene (red arrows) encodes
folylpolyglutamate synthase or FPGS and this enzyme has two activities. The first
activity adds L-glutamate to dihydropteroate and forms 7,8-dihydrofolate (DHF), while the
second activity adds 2-5 glutamates to form polyglutamylated THF species.
The folA gene (block arrow) encodes dihydrofolate reductase or DHFR; this enzyme
catalyzes the NADPH-dependent reduction of 7,8-dihydrofolate (DHF) to
5,6,7,8-tetrahydrofolate (THF). The glyA gene (green arrow) encodes
serine hydroxymethyl transferase or SHMT, which interconverts L-serine to
glycine using THF or 5, 10-methylene-THF and pyridoxal phosphate as a cofactor.
The metF gene (orange arrow) encodes methylene-tetrahydrofolate reductase or
MTHFR, which reduces N-5, 10-methylene-THF to 5-methyl-THF using NADPH
as a cofactor. The thyA gene (dark green) encodes thymidylate synthase or TS;
this enzyme catalyzes the transformation of methylene-THF to DHF.
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1.7.1 Plasmid encoded R67 Dihydrofolate Reductase (R67 DHFR)
R67 dihydrofolate reductase (DHFR), encoded by an R plasmid, provides resistance to the
antibacterial drug trimethoprim (TMP) [20]. This enzyme reduces 7,8-dihydrofolate (DHF) to
5,6,7,8-tetrahydrofolate (THF) Figure 1-11(below)While this is the same reaction catalyzed by
EcDHFR, the protein scaffold is different [20]. In E. coli K12, the concentration of DHF
(glutamate, and diglutamate forms) is 51 µM [36]. The R67 DHFR KM for DHF is only 5.8 µM
[20]. Thus, the R67 DHFR active site would be expected to be saturated with DHF in vivo [43].

Figure 1-11 R67 Dihydrofolate reductase activity.
R67 Dihydrofolate reductase catalyzes the reduction of 7, 8-dihydrofolate (DHF) to 5, 6, 7, 8tetrahydrofolate (THF) by a stereospecific hydride transfer from the NADPH cofactor to the
C6 atom of the pterin ring with a simultaneous protonation at N5. From http://en.wikipedia.
org/wiki/Dihydrofolate_reductase
R67 DHFR is a homotetramer (PDB: 2RK1) [8]; the active site and the C-terminus are
labeled in Figure 1-12 (below). Both DHF and NADPH bind in the central active site pore of the
enzyme [44]. The distance between the active site and the C-terminus is ≥19 Ǻ.
A tandem array of four fused R67 DHFR genes was previously constructed and a functional
enzyme named Quad4 resulted [5] (see a cartoon of the Quad4 structure in Figure 1-13 below). In
our in vivo study, we aim to study the effect of increasing osmolality on Quad4 in parallel to that
of R67 DHFR. Quad4 should have a single SsrA tag while R67 DHFR should have four SsrA
tags. The KM(DHF) of Quad4 is 5.6 ± 0.3

M [5], which is comparable to R67 DHFR.
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Figure 1-12 Structure of tetrameric R67 DHFR (1VIE).
The crystal structure of dimeric R67 DHFR shows 17-18 residues are disordered at the Nterminus [45]. When these residues are removed by chymotrypsin treatment, the truncated
species crystallizes as the active tetramer [46]. The active site and the C-terminus are
labeled above. Both DHF (substrate) and NADP+ are bound in the central active site pore
[44]. The distance between the active site and the C-terminus is ≥19 Ǻ. The figure was
constructed using Moe, version 2012.10 [30].

Figure 1-13 Quadruplicated construct of R67 DHFR: Quad4.
The four different colors represent the four fused R67 DHFR domains. The dashed lines
imagine the N-terminal 16 amino acids that would serve as the linker between domains. These
disordered amino acids are cleaved off to yield a truncated species that crystallizes as the
homotetramer [45, 46]. Similar to R67 DHFR, both the substrate and cofactor bind in the
central active site pore of the enzyme. The C-terminus is distant from the active site pore and
can accommodate a histag.
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1.7.2 Folylpolyglutamate Synthase (FPGS)
Folylpolyglutamate Synthase (FPGS) is a product of the folC gene [47]. This enzyme (EC
6.3.2.17) catalyzes two distinct reactions: the dihydrofolate synthase reaction adds L-glutamate to
dihydropteroate and forms dihydrofolate using ATP as an energy source and the
folylpolyglutamate synthase reaction extends the glutamate tail of THF using a γ-linkage Figure
1-14 (below) [47, 48]. Both THF and 10-formyl-THF are FPGS substrates.

This enzyme

participates at two separate positions in the folate cycle [35, 47] Figure 1-10 (above) (see red
arrows).

Figure 1-14 Two reactions-one enzyme: bifunctional FPGS.
The first reaction is a dihydrofolate synthase (DHFS) activity. DHFS adds L-glutamate to
dihydropteroate to form dihydrofolate (DHF) (TOP). In the second reaction, FPGS extends the
glutamate tail using a γ-linkage to form polyglutamylated folates (bottom) [35].
The concentrations of THF and 10-formyl-THF in E. coli K12 are 10 µM and 6.8 µM,
respectively [36]. The KM of THF for FPGS is 0.9 µM [47], and the KM of 10-formyl-THF is 17.0
µM [47]. For the latter reaction, the KM is higher than the concentration of 10-formyl-THF in vivo,
suggesting the active site of the enzyme may not be saturated in vivo. FPGS is a monomer (PDB:
1W78) [35]. The closest distance between the active site and C-terminus is 26 Ǻ. This great a
distance suggests addition of a SsrA tag would be tolerated Figure 1-15 (below/left). We also note
that a C-terminal histag version of the enzyme is available and active [36]. As an alternative to
the pKTS cloning, we also obtained two E. coli K12 mutant strains SF2 (folC strA) and SF4 (folC
strA recA Tn10::srlC) that carry an A309T mutation in the chromosomal folC gene [49] Figure
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1-15 (below/right). This mutant enzyme displays a 30 fold increase in Km for 10-CHO-THF, a 60
fold increase in the Km for glutamate, a 10 fold increase in the Km for ATP and a 200 fold increase
in the Km for dihydropteroate [49, 50]. Because of this drastic decrease in enzyme activity, we
proposed it might be possible to titrate FPGS activity by osmotic stress in the E. coli SF2 (folC
strA) strain.

Figure 1-15 The structure of FPGS and the position of A309T in the SF2
FPGS is a monomer (PDB: 1W78) [35]. Left image: the active site and the Cterminus are labeled. The distance between the active site and the C-terminus is ≥26
Ǻ. Right image: The E. coli SF2 strain contains a G925A mutation in the FolC gene
corresponding to an A309T mutation in FPGS. The figure was constructed using
MOE, version 2012.10 [30].
1.7.3 5, 10-Methylenetetrahydrofolate Reductase (MTHFR)
Methylenetetrahydrofolate Reductase (E.C. 1.5.1.20) is encoded by the metF gene. This
enzyme catalyzes the reduction of 5,10-methylene-THF to 5-methyl-THF using NAD(P)H as a
cofactor Figure 1-16 (below) [34, 51]. The 5-methyl-THF product serves as a methyl group donor
for the subsequent conversion of homocysteine to methionine by methionine synthase [34]. In E.
coli K12, the concentration of 5,10-methylene-THF (diglutamate, triglutamate, tetraglutamate and
pentaglutamate forms) is 22.24 µM [36]. The KM is only 0.8 µM [34], suggesting the enzyme will
be saturated in vivo.

19

Figure 1-16 Sequental catalytic mechanism of (MTHFR).
MTHFR catalyzes the reduction of 5,10 methylene-tetrahydrofolate (CH2-THF) to 5-methyltetrahydrofolate (CH3-THF) using NADPH and flavin adenine dinucleotide (FAD) as
coenzymes. MTHFR uses a sequential mechanism in which NAD(P)+ release is followed by
the binding of CH2-THF and the subsequent release of CH3-THF after reaction with the flavin.
Equations from [51].
MTHFR is a tetramer (PDB: 1ZPT) Figure 1-17 (below) [52]; the closest distance between
the active site and C-terminus is 25 Ǻ. Thus, addition of an SsrA tag should not interfere with the
activity of the enzyme. Even though all of our criteria were not satisfied, the importance of this
enzyme in the folate cycle and its association to heart disease [53 511] made this enzyme an
attractive target for our study.

Figure 1-17 Crystal structure of methylene-tetrahydrofolate reductase (MTHFR)
MTHFR is a tetramer (PDB: 1ZPT), the active site and C-terminus of a monomer are labeled.
The distance between the active site and C-terminus is ≥ 25 Ǻ [33]. The figure was constructed
using MOE version 2012.10 [30].

20

1.7.4 Serine Hydroxymethyl Transferase (SHMT)
Serine hydroxymethyl transferase (SHMT) (EC. 2.1.2.1) is the product of the GlyA gene.
SHMT converts serine to glycine using pyridoxal phosphate (PLP) as a coenzyme. SHMT
catalyzes two coordinated reactions, cleavage of PLP-serine to form PLP-glycine, and
condensation of the formaldehyde with THF to form 5,10-methenyltetrahydrofolate [54]. A
simplified reaction is shown in Figure 1-18 (below). SHMT is a dimer (PDB = IDFO) Figure 1-19
(below). In E. coli K12, the THF concentration (in all glutamylation states) is 10.02 µM [36]. The
enzyme follows a sequential reaction mechanism; the KM for THF is 25 µM [55]. The KM is higher
than the concentration of the metabolites in vivo [36], suggesting we may be able to titrate its
activity. Finally, the distance between the active site and the C-terminus is ~25 Å, suggesting
addition of a SsrA tag would not interfere with the catalytic site of the enzyme.

Figure 1-18 Serine hydroxymethyltransferase catalyzes reversible reaction
SHMT catalyzes the THF dependent cleavage of serine to form 5, 10-THF and glycine.
Adapted from: http://2012.igem.org/Team:Utah_ State/Project

Figure 1-19 Crystal structure of serine hydroxymethyltransferase (SHMT)
SHMT is a dimer (PDB:1DFO). One active site and C-terminus (shown in green) are labeled.
The distance between the active site and the C-terminus is ≥25 Ǻ. The figure was constructed
using MOE, version 2012.10 [30].
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1.7.5 Dihydropteroate Synthase (DHPS)
DHPS (EC 2.5.1.15) catalyzes the formation of dihydropteroate from dihydropteroate-6pyrophosphate (H2PtPP) and p-aminobenzoic acid (pABA) Figure 1-20 (below). The in vivo pABA
concentration is 0.02 µM [36]. The KMs for H2PtPP and pABA are 1.2 ± 0.4 µM and 0.7 ± 0.2 µM,
respectively [56]. Dihydropteroate synthase (PDB:1JAO) is a monomer Figure 1-21 (below). The
distance between the active site and C-terminus is ≥ 22 Å.

Figure 1-20 Dihydropteroate synthase (DHPS) joins pterin and pABA moieties
This enzyme joins the activated 6-hydroxymethyl-7,8-dihydropterin pyrophosphate (DHPPP)
with para-amino benzoic acid (pABA) to produce 7, 8-dihydropteroate [57].

Figure 1-21 Crystal structure of dihydropteroate synthase (DHPS)
DHPS is a monomer, the active site and C-terminus are labeled (PDB: 3KUH). The distance
between the active site and C-terminus is ≥22 Ǻ. DHPS is also of interest as it provides
resistance to sulfa drugs. The figure was constructed using MOE version 2012.10 [30].
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1.7.6 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase (HPPK)
6-Hydroxymethyl-7, 8-dihydropterin pyrophosphokinase (HPPK) (EC 2.7.6.3) catalyzes the
transfer of pyrophosphate from ATP to 6-hydroxymethyl 7, 8-dihydropterin (HMDP) and forms
6-hydroxymethyl-7, 8-dihydropterin pyrophosphate (DHPPP) [58] [59]. In E. coli, the
concentration of ATP is 9.6 mM [43]. The KMs for HMDP and ATP are 0.68 µM and 3.44 µM,
respectively [59]. Since neither the substrate nor product of this enzyme reaction is particularly
stable, this may be why we did not find their in vivo concentrations.

Figure 1-22 The 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase (HPPK)
HPPK catalyzes the activation of 6-hydroxymethyl-7,8-dihydropterin (HMDP) by ATP to form
6-hydroxymethyl-7,8-dihydropterin pyrophosphate (DHPPP). From [57]

Figure 1-23 6-Hydroxymethyl-7,8-dihydropterin pyrophosphokinase (HPPK)
HPPK is a monomer (PDB: 3KUH). The active site and the C-terminus are labeled. The distance
between the active site and C-terminus is ≥9 Ǻ.
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1.7.7 Thymidylate Synthase (TS)
Thymidylate synthase (E.C. 2.1.1.45) catalyzes the conversion of deoxyuridine
monophosphate (dUMP) to deoxythymidine monophosphate (dTMP). During this process, the
5,10-CH2-THF cofactor is converted to DHF. This enzyme is a product of the ThyA gene. TS plays
a major role in pyrimidine biosynthesis and it is the only de novo source of dTMP Figure 1-24
(below) [48, 60]. In E.coli K12, the concentration of 5,10-CH2-THF is 22.42 µM [48]. The KM
values for CH2-THF and dUMP are 11 µM [36] and 1.2 µM [31], respectively. However, the
enzyme active site is close to the C-terminus and the carboxyl group (-COO-) is involved in
positioning the ligands at the active site [61]. Any additions to the C-terminus inactivate the
enzyme. In addition, the N-terminal methionine is formylated and the formyl group forms a
hydrogen bond with Thr46 and Thr47 Figure 1-25 (below). Thus, attaching the protease
degradation tag at either N-terminus or C-terminus does not appear possible. In addition, no histag
clones exist for this enzyme.

Figure 1-24 Thymidylate synthase (TS) plays a major role in DNA synthesis.
This enzyme catalyzes the conversion of deoxyuridine monophosphate (dUMP) to
deoxythymidine monophosphate (dTMP) using 5,10-methylene tetrahydrofolate (CH2THF) as
a methyl group donor. From: http://www.cliffsnotes.com/sciences/biology/biochemistryii/purines-and-pyrimidines/deoxynucleotide-synthesis
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Figure 1-25 Crystal structure of thymidylate Synthase (TS)
TS is a dimer. In panel (A), the active site and C-terminus are labeled. Panel B -The Nterminus is formlyated; this group forms a hydrogen bond with Thr46 and Thr47. Panel C- The
distance between the active site and C-terminus is ≤ 5 Ǻ and the C terminal carboxylate of the
enzyme plays a role in adjusting the position of the ligands in the active site (PDB:1AXW)
[61].
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CHAPTER
2
2.1

Chapter 2: Materials and Methods

Materials and

Methods

Brief summary and step wise processes and rationales
The below flow chart summarizes the theoretical and experimental processes and structure

of this thesis. First, we identify and select essential folate enzymes. Second, for the purpose of
decreasing the in vivo protein production, the coding sequence for selected enzymes was cloned
into the tunable plasmid, pKTS. The clones of interest were obtained by introducing NdeI and
XhoI recognition sequences within open reading frame of the gene via PCR and/or a commercial
gene synthesis service. Third, pKTS carrying the gene of interest was transformed into a
corresponding knockout E. coli strain. Fourth, the desired in vivo protein production level that
allowed rescue of the auxotrophic strain to prototrophy (regulated via Ptet promoter) was
determined by tetracycline titration. Fifth, to assess the effect of increasing osmolality on the
function of the targeted folate pathway enzyme, the internal osmolality of E. coli was titrated by
exogenous sorbitol in minimal growth media. Finally, the effect of increasing osmolality on the
function of the enzyme was analyzed based whether the cloned enzyme could maintain prototrophy
for the auxotrophic strain. To control for the osmotic fitness of the host cell, parallel cell growth
assays were performed on supplemented media. The osmotic fitness of the host cell was estimated
based on the osmolality of supplemented growth media where the bacteria stopped growing. The
flow chart in Figure 2-1 (below) shows the steps in the experimental process.
2.2

Biological Materials

2.2.1 Bacterial strains
The E. coli strains used in this study are listed in Table 2-1 (below). Most strains contain a
knockout in a folate pathway enzyme, resulting in some type of folate end product auxotrophy. In
this study, the effect of increasing osmolality on the function of the enzyme was evaluated by the
ability of the clone to rescue the host cell to prototrophy. Most of the Keio knockout strains [26]
were purchased from the Coli Genetic Stock Center (CGSC, see http://cgsc.biology.yale.edu/).
Other strains were requested from the lab that constructed the specific gene knockout.
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Figure 2-1 Flow chart describing the general work flow.
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Table 2-1 List of E. coli strains, their genotypes, and sources

Strain

Genotype

Source

DH5α

F - Φ80lacZΔM15(lacZYA-argF) U169 recA1
endA1 hsdR17 (rK–, mK+) phoA supE44 λ–thi-1
gyrA96 relA1

Invitrogen [62]

LH18

Howell [63]

W1485

Δlac-pro supE hsdRS F' lac(l-ZΔM15)+ pro'
∆folA::kan
F + λ- rph-1 (also known as MG1655)

SF2

W1485/I-21 (F- folC strA)

Bognar [49, 64]

SF4
BW25113

F- λ- rph-1 folC strA recA TN10:srlC
F - Δ(araD-araB)567 ΔlacZ4787(::rrnB-3) λ- rph1 Δ(rhaD-rhaB)568 hsdR514

CGSC [26]

JW2535-1

BW25113 ΔglyA725::kan

CGSC [26]

JW3913-1

BW25113 ΔmetF728::kan

CGSC [26]

C600 ∆folK::tc (thi-1 thr-1 leuB6 lacY1 tonA21
supE44)
C600
C600 ΔfolP::kan(thi-1 thr-1 leuB6 lacY1 tonA21
supE44)
E. coli
F’cells [lacIq Tn10(tetR)] mcrA Δ(mrr-hsdRMSone shot ®TOP10F mcrBC) φ80lacZΔM15 ΔlacX74 deoR nupG
competent cells *
recA1 araD139 Δ(ara-leu)7697 galU galK
rpsL(StrR) endA1 λ* The E. coli Top 10 cell line was used for TOPO-TA cloning
C600

CGSC [26]

Swedberg [65]
Swedberg [65]
Invitrogen [66]

2.2.2 Plasmids
Clones of the folate pathway enzymes were obtained from various research labs. The
source of these clones and some information concerning the clones are given in Table 2-1 (above).
The pKTS plasmid was obtained from Donald Hilvert (ETH Zurich) [4]. This plasmid enables
control of gene expression via the Ptet promoter and the SsrA protease degradation tag helps
decrease the gene product concentration in vivo. The clones were confirmed via sequencing.
Briefly, ~ 40 ng of DNA of each clone was transformed into E. coli DH5a (Invitrogen) using the
heat shock method. Immediately after the heat shock, 950 µL of S.O.C media (2 % tryptone, 0.5
% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, and 20 mM glucose)
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was added and the samples were placed on a shaker (~200 rpm) at 37 oC for about one hour. Next
50 µL and 100 µL cells were plated on YT agar media with the appropriate antibiotic added. After
overnight growth, three to five colonies were picked and grown in YT broth with 200 µg
ampicillin/ml at 37 oC. Finally, the plasmid DNA was extracted with the Wizard Miniprep DNA
purification system and the quality of the genes was confirmed via DNA sequencing at the
Molecular Biology Resource facility (University of Tennessee, Knoxville).

Table 2-2 List of folate enzyme clones
Gene Enzyme (Abbreviation)

Plasmid Name

Source of cloned

folA

pAG101
(EcDHFR)
pUC57

Howell [5, 67, 68]

Dihydrofolate reductase (DHFR)
R67 DHFR/Quad4 (Type II)
Trimethoprim resistance [19]

folC

Folylpolyglutamate synthase
(FPGS)

pAC5a, pAC3b
and pPM103

Bognar [50, 69]

folP

Dihydropteroate synthase
(DHPS)
Sulfonamide resistance [70]

pUC19

Swedberg (E. coli) Lee (S.
aureus)
[65, 71-73]

folK

6-Hydroxymethyl-7,8dihydropterin
pyrophosphokinase

pTT5

Yan [74-76]

glyA

Serine hydroxymethyl
transferase (SHMT)

pSGlyA
(pBR322),
(Bluescript KS)

Contestabile [77-79]

pCAS30

Trimmer/Matthews [34]

metF Methylene-tetrahydrofolate
reductase (MTHFR)
a:

pUC9 with folC gene downstream of lac promoter; Amp resistance
pUC8 with 3.5-kb fragment containing usg, folC, and dedD genes; Amp resistance
c: pSC101 temperature sensitive for replication; segregates above 30°C; Tet resistance
b:

The DNA sequences of the above genes were obtained from http://www.genome.jp/keggbin/show_organism?org=eco. Table 2-3(below) gives the gene sequences and the translated
protein sequences [80].
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Table 2-3 E coli 1C metabolism genes DNA sequences and their corresponding protein products

R67 DHFR

(Type II)

Quad4

(Quadruplicated synthetic R67 DHFR)

Gene
(Abbreviation)

DNA and protein sequence
atgatcaggagctctaatgaagtttcgaatccagttgccggcaattttgtattcccttcg
M I R S S N E V S N P V A G N F V F P S
aacgccacgtttggtatgggtgaccgcgtacgtaagaaatccggcgccgcctggcaaggt
N A T F G M G D R V R K K S G A A W Q G
cagattgtcgggtggtactgcacaaatttgacccctgagggctacgccgtcgagtctgag
Q I V G W Y C T N L T P E G Y A V E S E
gctcacccgggctcagtacagatctatcctgttgcggcgcttgaacgcatcaactaa
A H P G S V Q I Y P V A A L E R I N atgatcaggagctctaatgaagtttcgaatccagttgccggcaattttgtattcccatcg
M I R S S N E V S N P V A G N F V F P S
aacgccacgtttggtatgggtgaccgcgtacgtaagaaatccggcgccgcctggcaaggt
N A T F G M G D R V R K K S G A A W Q G
cagattgtcgggtggtactgcacaaatttgacccctgagggctacgccgtcgaggctgag
Q I V G W Y C T N L T P E G Y A V E A E
gctcatccgggctcagtacagatctatcctgttgcggcgcttgaacgcatcgatatcgat
A H P G S V Q I Y P V A A L E R I D I D
cagcataacaatggcgttagcaccctggtggcaggtcagtttgccttacctagccatgcg
Q H N N G V S T L V A G Q F A L P S H A
acctttggcctgggtgaccgcgtccggaaaaagagtggcgccgcttggcagggacaagtc
T F G L G D R V R K K S G A A W Q G Q V
gtgggctggtattgcaccaagcttaccccggaaggttacgcggtagagagcgaatcgcat
V G W Y C T K L T P E G Y A V E S E S H
cctggaagcgtgcaaatttatccggtcgctgctctcgagcgaaggtacctcaatgagggc
P G S V Q I Y P V A A L E R R Y L N E G
aaaaatgaggtgtctacgtctgccgccggccgcttcgccttcccttcgaatgccactttc
K N E V S T S A A G R F A F P S N A T F
ggtctcggcgatcgtgttcgcaaaaagagcggcgccgcatggcaggggcgtatcgtaggt
G L G D R V R K K S G A A W Q G R I V G
tggtattgtactaccttaacgccggaggggtatgcagtggaaagtgagagccatccaggg
W Y C T T L T P E G Y A V E S E S H P G
agtgtccaaatttaccccatgaccgccttagagcgcagggccctgggccagagctctcat
S V Q I Y P M T A L E R R A L G Q S S H
gaagccaacgccccagtggccggccagttcgccctgcctctgagcgccacgtttggtttt
E A N A P V A G Q F A L P L S A T F G F
ggcgatcgtgttcgcaagaaatctggcgccgcgtggcaaggcaacgtggttggatggtac
G D R V R K K S G A A W Q G N V V G W Y
tgtacgaaactcactcccgaaggatatgctgttgaatcggaaagcctcccaggttccgtt
C T K L T P E G Y A V E S E S L P G S V
cagatctacccagtggcagcactcgaacgaatcaacggaggcggtggtcatcaccatcac
Q I Y P V A A L E R I N G G G G H H H H
catcac
H H
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Table 2-3 Continued

(FPGS)

folC

Gene
(Abbreviation)

DNA and protein sequence
atgattatcaaacgcactcctcaagccgcgtcgcctctggcttcgtggctttcttatctg
M I I K R T P Q A A S P L A S W L S Y L
gaaaacctgcacagtaaaactatcgatctcggccttgagcgcgtgagcctggtcgcggcg
E N L H S K T I D L G L E R V S L V A A
cgtcttggcgtcctgaaaccagcgccatttgtgtttaccgttgcgggtacgaatggcaaa
R L G V L K P A P F V F T V A G T N G K
ggcaccacctgccgtacgctggagtcgattctgatggcggcagggtacaaagtgggcgtc
G T T C R T L E S I L M A A G Y K V G V
tacagttcgcctcatctggtgcgttataccgagcgcgtacgtgtgcagggccaggaattg
Y S S P H L V R Y T E R V R V Q G Q E L
ccggaatcggcccacaccgcctcttttgcggagattgaatcggcacgcggtgatatttcc
P E S A H T A S F A E I E S A R G D I S
ctgacctatttcgagtacggtacgctgtcggcgttgtggctgttcaagcaggcacaactt
L T Y F E Y G T L S A L W L F K Q A Q L
gacgtggtgattctggaagtagggctgggcggtcgtctggacgcaaccaatattgtcgac
D V V I L E V G L G G R L D A T N I V D
gccgatgtcgcggtagtaaccagtattgcgctggatcataccgactggctgggtccagat
A D V A V V T S I A L D H T D W L G P D
cgcgaaagtattggtcgcgagaaagcaggcatcttccgcagcgaaaaaccggcaattgtc
R E S I G R E K A G I F R S E K P A I V
ggtgagccggaaatgccttctaccattgctgatgtggcgcaggaaaaaggtgcactgtta
G E P E M P S T I A D V A Q E K G A L L
caacgtcggggcgttgagtggaactattccgtcaccgatcatgactgggcgtttagcgat
Q R R G V E W N Y S V T D H D W A F S D
gctcacggcacgctggaaaatctgccgttgccgcttgtcccgcaaccgaatgccgcaaca
A H G T L E N L P L P L V P Q P N A A T
gcgctggcggcactgcgtgccagcgggctggaagtcagtgaaaatgccattcgcgacggg
A L A A L R A S G L E V S E N A I R D G
attgccagcgcaattttgccgggacgtttccagattgtgagcgagtcgccacgcgttatt
I A S A I L P G R F Q I V S E S P R V I
tttgatgtcgcgcataatccacatgcggcggaatatctcaccgggcgtatgaaagcgcta
F D V A H N P H A A E Y L T G R M K A L
ccgaaaaacgggcgcgtgctggcggttatcggtatgctacatgataaagatattgccgga
P K N G R V L A V I G M L H D K D I A G
actctggcctggttgaaaagcgtggttgatgactggtattgtgcgccactggaagggccg
T L A W L K S V V D D W Y C A P L E G P
cgcggtgccacggcagaacaactgcttgagcatttgggtaacggcaaatcatttgatagc
R G A T A E Q L L E H L G N G K S F D S
gttgcgcaggcatgggatgccgcaatggcggacgctaaagcggaagacaccgtgctggtg
V A Q A W D A A M A D A K A E D T V L V
tgtggttctttccacacggtcgcacatgtcatggaagtgattgacgcgaggagaagcggt
C G S F H T V A H V M E V I D A R R S G
ggcaagtaa
G K -
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Table 2-3 Continued

falK

(HPPK)

falP

(DHPS)

Gene
(Abbreviation)

DNA and protein sequence
atgacagtggcgtatattgccataggcagcaatctggcctctccgctggagcaggtcaat
M T V A Y I A I G S N L A S P L E Q V N
gctgccctgaaagcattaggcgatatccctgaaagccacattcttaccgtttcttcgttt
A A L K A L G D I P E S H I L T V S S F
taccgcaccccaccgctggggccgcaagatcaacccgattacttaaacgcagccgtggcg
Y R T P P L G P Q D Q P D Y L N A A V A
ctggaaacctctcttgcacctgaagagctactcaatcacacacagcgtattgaattgcag
L E T S L A P E E L L N H T Q R I E L Q
caaggtcgcgtccgcaaagctgaacgctggggaccacgcacgctggatctcgacatcatg
Q G R V R K A E R W G P R T L D L D I M
ctgtttggtaatgaagtgataaatactgaacgcctgaccgttccgcactacgatatgaag
L F G N E V I N T E R L T V P H Y D M K
aatcgtggatttatgctgtggccgctgtttgaaatcgcgccggagttggtgtttcctgat
N R G F M L W P L F E I A P E L V F P D
ggggagatgttgcgtcaaatcttacatacaagagcatttgacaaattaaacaaatggtaa
G E M L R Q I L H T R A F D K L N K W atgaaactctttgcccagggtacttcactggaccttagccatcctcacgtaatggggatc
M K L F A Q G T S L D L S H P H V M G I
ctcaacgtcacgcctgattccttttcggatggtggcacgcataactcgctgatagatgcg
L N V T P D S F S D G G T H N S L I D A
gtgaaacatgcgaatctgatgatcaacgctggcgcgacgatcattgacgttggtggcgag
V K H A N L M I N A G A T I I D V G G E
tccacgcgcccaggggcggcggaagttagcgttgaagaagagttgcaacgtgttattcct
S T R P G A A E V S V E E E L Q R V I P
gtggttgaggcaattgctcaacgcttcgaagtctggatctcagtcgatacatccaaacca
V V E A I A Q R F E V W I S V D T S K P
gaagtcatccgtgagtcagcgaaagttggcgctcacattattaatgatatccgctccctt
E V I R E S A K V G A H I I N D I R S L
tccgaacctggcgctctggaggcggctgcagaaaccggtttaccggtttgtctgatgcat
S E P G A L E A A A E T G L P V C L M H
atgcagggaaatccaaaaaccatgcaggaagctccgaagtatgacgatgtctttgcagaa
M Q G N P K T M Q E A P K Y D D V F A E
gtgaatcgctactttattgagcaaatagcacgttgcgagcaggcgggtatcgcaaaagag
V N R Y F I E Q I A R C E Q A G I A K E
aaattgttgctcgaccccggattcggtttcggtaaaaatctctcccataactattcatta
K L L L D P G F G F G K N L S H N Y S L
ctggcgcgcctggctgaatttcaccatttcaacctgccgctgttggtgggtatgtcacga
L A R L A E F H H F N L P L L V G M S R
aaatcgatgattgggcagctgctgaacgtggggccgtccgagcgcctgagcggtagtctg
K S M I G Q L L N V G P S E R L S G S L
gcctgtgcggtcattgccgcaatgcaaggcgcgcacatcattcgtgttcatgacgtcaaa
A C A V I A A M Q G A H I I R V H D V K
gaaaccgtagaagcgatgcgggtggtggaagccactctgtctgcaaaggaaaacaaacgc
E T V E A M R V V E A T L S A K E N K R
tatgagtaa
Y E -
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Table 2-3 Continued

(SHMT)

glyA

Gene
(Abbreviation)

DNA and protein sequence
atgttaaagcgtgaaatgaacattgccgattatgatgccgaactgtggcaggctatggag
M L K R E M N I A D Y D A E L W Q A M E
caggaaaaagtacgtcaggaagagcacatcgaactgatcgcctccgaaaactacaccagc
Q E K V R Q E E H I E L I A S E N Y T S
ccgcgcgtaatgcaggcgcagggttctcagctgaccaacaaatatgctgaaggttatccg
P R V M Q A Q G S Q L T N K Y A E G Y P
ggcaaacgctactacggcggttgcgagtatgttgatatcgttgaacaactggcgatcgat
G K R Y Y G G C E Y V D I V E Q L A I D
cgtgcgaaagaactgttcggcgctgactacgctaacgtccagccgcactccggctcccag
R A K E L F G A D Y A N V Q P H S G S Q
gctaactttgcggtctacaccgcgctgctggaaccaggtgataccgttctgggtatgaac
A N F A V Y T A L L E P G D T V L G M N
ctggcgcatggcggtcacctgactcacggttctccggttaacttctccggtaaactgtac
L A H G G H L T H G S P V N F S G K L Y
aacatcgttccttacggtatcgatgctaccggtcatatcgactacgccgatctggaaaaa
N I V P Y G I D A T G H I D Y A D L E K
caagccaaagaacacaagccgaaaatgattatcggtggtttctctgcatattccggcgtg
Q A K E H K P K M I I G G F S A Y S G V
gtggactgggcgaaaatgcgtgaaatcgctgacagcatcggtgcttacctgttcgttgat
V D W A K M R E I A D S I G A Y L F V D
atggcgcacgttgcgggcctggttgctgctggcgtctacccgaacccggttcctcatgct
M A H V A G L V A A G V Y P N P V P H A
cacgttgttactaccaccactcacaaaaccctggcgggtccgcgcggcggcctgatcctg
H V V T T T T H K T L A G P R G G L I L
gcgaaaggtggtagcgaagagctgtacaaaaaactgaactctgccgttttccctggtggt
A K G G S E E L Y K K L N S A V F P G G
cagggcggtccgttgatgcacgtaatcgccggtaaagcggttgctctgaaagaagcgatg
Q G G P L M H V I A G K A V A L K E A M
gagcctgagttcaaaacttaccagcagcaggtcgctaaaaacgctaaagcgatggtagaa
E P E F K T Y Q Q Q V A K N A K A M V E
gtgttcctcgagcgcggctacaaagtggtttccggcggcactgataaccacctgttcctg
V F L E R G Y K V V S G G T D N H L F L
gttgatctggttgataaaaacctgaccggtaaagaagcagacgccgctctgggccgtgct
V D L V D K N L T G K E A D A A L G R A
aacatcaccgtcaacaaaaacagcgtaccgaacgatccgaagagcccgtttgtgacctcc
N I T V N K N S V P N D P K S P F V T S
ggtattcgtgtaggtactccggcgattacccgtcgcggctttaaagaagccgaagcgaaa
G I R V G T P A I T R R G F K E A E A K
gaactggctggctggatgtgtgacgtgctggacagcatcaatgatgaagccgttatcgag
E L A G W M C D V L D S I N D E A V I E
cgcatcaaaggtaaagttctcgacatctgcgcacgttacccggtttacgcataa
R I K G K V L D I C A R Y P V Y A -
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2.3

(MTHFR)

metF

Gene
(Abbreviation)

DNA and protein sequence
atgagcttttttcacgccagccagcgggatgccctgaatcagagcctggcagaagtccag
M S F F H A S Q R D A L N Q S L A E V Q
gggcagattaacgtttcgttcgagtttttcccgccgcgtaccagtgaaatggagcagacc
G Q I N V S F E F F P P R T S E M E Q T
ctgtggaactccatcgatcgccttagcagcctgaaaccgaagtttgtatcggtgacctat
L W N S I D R L S S L K P K F V S V T Y
ggcgcgaactccggcgagcgcgaccgtacgcacagcattattaaaggcattaaagatcgc
G A N S G E R D R T H S I I K G I K D R
actggtctggaagcggcaccgcatcttacttgcattgatgcgacgcccgacgagctgcgc
T G L E A A P H L T C I D A T P D E L R
accattgcacgcgactactggaataacggtattcgtcatatcgtggcgctgcgtggcgat
T I A R D Y W N N G I R H I V A L R G D
ctgccgccgggaagtggtaagccagaaatgtatgcttctgacctggtgacgctgttaaaa
L P P G S G K P E M Y A S D L V T L L K
gaagtggcagatttcgatatctccgtggcggcgtatccggaagttcacccggaagcaaaa
E V A D F D I S V A A Y P E V H P E A K
agcgctcaggcggatttgcttaatctgaaacgcaaagtggatgccggagccaaccgcgcg
S A Q A D L L N L K R K V D A G A N R A
attactcagttcttcttcgatgtcgaaagctacctgcgttttcgtgaccgctgtgtatcg
I T Q F F F D V E S Y L R F R D R C V S
gcgggcattgatgtggaaattattccgggaattttgccggtatctaactttaaacaggcg
A G I D V E I I P G I L P V S N F K Q A
aagaaatttgccgatatgaccaacgtgcgtattccggcgtggatggcgcaaatgttcgac
K K F A D M T N V R I P A W M A Q M F D
ggtctggatgatgatgccgaaacccgcaaactggttggcgcgaatattgccatggatatg
G L D D D A E T R K L V G A N I A M D M
gtgaagattttaagccgtgaaggagtgaaagatttccacttctatacgcttaaccgtgct
V K I L S R E G V K D F H F Y T L N R A
gaaatgagttacgcgatttgccatacgctgggggttcgacctggtttataa
E M S Y A I C H T L G V R P G L -

Cloning

2.3.1 Competent cell preparation
2.3.2 Chemically competent cell preparation.
Chemically competent cells for each E. coli strain of interest, in particular the knockout
strains listed in Table 2-1 (above), were made following general molecular biology techniques.
Briefly a starter culture of the E. coli knockout strain was grown in 10 mL YT broth with selective
antibiotic and required folate end product(s). (The list of required folate end products for each
enzyme is given in Table 2-5 (below). Next, 1% of starter culture was transferred into 50 mL fresh
YT broth with antibiotic. After the cells had reached an OD600 of ~0.4-0.6, the cell suspension was
spun down in a Sorvall RC-6 Plus centrifuge using a SS-34 rotor at 6100 rpm for 5 minutes. The
pellet was washed twice with wash buffer (5 mM Tris-HCl pH 7.6, 10 mM MgCl2 and 50 mM
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NaCl) and re-suspended twice. Then, the cell pellet was re-suspended in a CaCl2 buffer (10 mM
Tris-HCL pH 7.6, 10 mM MgCl2, and 10 mM CaCl2) and incubated for 30 min on ice. Next, the
cells were spun down and CaCl2 buffer was removed. The pellet was re-suspended with ice cold
storage buffer (CaCl2 buffer with 15% glycerol) and 100 μL cell suspensions were aliquoted into
sterile 1.5 mL microfuge tubes. These samples were snap frozen with dry ice and stored at -80°C
[81].
Electrocompetent cell preparation
Electrocompetent cells of each E. coli knockout strain of interest were made following the
protocol in the MicropulserTM electroporation apparatus operation manual (cat 165-2100) [82].
Briefly, a 10 ml starter culture of a knockout strain was grown in 50 mL of SOB-Mg- (without
Magnesium) 0.5 % tryptone, 0.5 % yeast extract, 10 mM NaCl, 1.34 mM KCl) broth with selective
antibiotic and required folate end product(s). Next, 1% of starter culture was transferred into 50
mL fresh YT broth with antibiotic and required folate end product(s). After the cells reached an
OD600 of ~0.5-0.7, they were centrifuged in a Sorvall centrifuge using a SS-34 rotor at 6,100 rpm.
The pellet was washed twice with ice-cold 10 % glucose solution. Then, the cells were resuspended in a final volume of 1-2 mL with ice-cold 10 % glucose solution and 100 μL cells were
aliquoted into sterile 1.5 mL microfuge tubes. These samples were snap frozen with dry ice and
stored in the -80°C freezer.
2.3.3 Introduction of NdeI and/or XhoI recognition sequences
The pKTS plasmid has NdeI and XhoI cloning sites between the Ptet promoter and the SsrA
degradation tag. These two restriction enzyme sites needed to be introduced at the 5’ and 3’ ends
of the genes of interest. Two methods were used to introduce the sequences, as described below.
Chemical Synthesis
Chemical Synthesis: For R67 DHFR and Quad4 genes, NdeI and XhoI recognition sites
were added to the 5’ and 3’ ends of these genes by chemical synthesis by Genscript (USA, Inc.).
The genes were supplied as clones in pUC57.
To decrease the activity of DHPS, a ‘pessimal’ DNA sequence was designed in
collaboration with Mike Gilchrist (Ecology and Evolutionary Biology department, University of
TN, Knoxville). A pessimal sequence is the opposite of an optimized sequence as low frequency
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use codons are utilized in the design process. The ‘pessimal’ sequence with NdeI and XhoI
recognition sites was chemically synthesized and supplied as a clone in the pET 3a vector by
Genscript (USA, Inc). The gene sequence is shown below:

atgaagctatttgcccaaggaacatcactagatctaagtcatccccatgtcatgggaata
M K L F A Q G T S L D L S H P H V M G I
ctaaatgtcacacccgattcattttcagatggaggaacacataattcactaatagatgcc
L N V T P D S F S D G G T H N S L I D A
gtcaagcatgccaatctaatgataaatgccggagccacaataatagatgtcggaggagag
V K H A N L M I N A G A T I I D V G G E
tcaacaagacccggagccgccgaggtcagtgtcgaggaggagctacaaagagtcataccc
S T R P G A A E V S V E E E L Q R V I P
gtcgtcgaggccatagcccaaagatttgaggtctggatatcagtcgatacatcaaagccc
V V E A I A Q R F E V W I S V D T S K P
gaggtcataagagagtcagccaaggtcggagcccatataataaatgatataagatcacta
E V I R E S A K V G A H I I N D I R S L
tcagagcccggagccctagaggccgccgccgagacaggactacccgtctgtctaatgcat
S E P G A L E A A A E T G L P V C L M H
atgcaaggaaatcccaagacaatgcaagaggcccccaagtatgatgatgtctttgccgag
M Q G N P K T M Q E A P K Y D D V F A E
gtcaatagatattttatagagcaaatagccagatgtgagcaagccggaatagccaaggag
V N R Y F I E Q I A R C E Q A G I A K E
aagctactactagatcccggatttggatttggaaagaatctatcacataattattcacta
K L L L D P G F G F G K N L S H N Y S L
ctagccagactagccgagtttcatcattttaatctacccctactagtcggaatgtcaaga
L A R L A E F H H F N L P L L V G M S R
aagtcaatgataggacaactactaaatgtcggaccctcagagagactaagtggaagtcta
K S M I G Q L L N V G P S E R L S G S L
gcctgtgccgtcatagccgccatgcaaggagcccatataataagagtccatgatgtcaag
A C A V I A A M Q G A H I I R V H D V K
gagacagtcgaggccatgagagtcgtcgaggccacactatcagccaaggagaataagaga
E T V E A M R V V E A T L S A K E N K R
tatgagtaa
Y E -
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PCR Method
PCR method: For the other two folate genes encoding metF and glyA, NdeI and/or XhoI
restriction sites were introduced with the polymerase chain reaction (PCR). For metF, the forward
and reverse primers were designed following the protocol described on the Oxford Genetics
website [83]. Briefly, upstream from the start codon of metF, the NdeI recognition sequence ‘CAT’
and six non-complementary TA bases were added. Then 21 coding bases for metF were included.
The TM of the primer was estimated using the New England BioLabs (NEB) TM calculator [84].
In the metF clone, a XhoI restriction site was already present at the end of the gene. Therefore, the
reverse primer was designed using 25 complementary bases that were upstream of the XhoI site.
The annealing temperature was calculated by subtracting 5 0C from the lowest TM estimated for
the forward and reverse primers. The sequences of the primers are listed in Table 2-4 (below).
The PCR primers for the glyA gene were designed by a similar approach. The forward
primer possessed 39 bases from the coding sequence with an added Nde1 site. Similarly, the
reverse primer was designed with 20 complementary bases upstream of the stop codon. Then a
XhoI recognition sequence was added as well as an extended ‘GC’ sequence. The TM values for
the primers were estimated using the New England BioLabs (NEB) TM calculator [84] . The
sequences of the primers are listed in Table 2-4(below).
The PCR amplification reaction was carried out in 50 l reaction volumes using 0.50 μM
forward and reverse primers, 200 mM dNTPs (Fisher), 1.5 mM MgCl2 and 1X PCR buffer (100
mM Tris-HCl, pH 9.0; 500 mM KCl; 15 mM MgCl2) (Fisher) and 1 Unit Taq DNA polymerase
(Fisher) and 5 to 100 ng DNA template. The reaction was carried out in a 0.2 l PCR tube in a
DNA thermal cycler (Bio-Rad). The reaction conditions were 95 oC for 5 minutes, with 35 cycles
of (95 oC for 30 seconds, annealing temperature (~the lowest of the TM – 5 0 C) as listed in Table
5 for 45 seconds, 72 oC for 1-2 minute), and a final extension of 72 oC for 15 minutes.
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Table 2-4 List of PCR primer sequences used to introduce Nde1 and/or Xho1 restriction enzyme
sites with their calculated TM values.
Enzyme
name
MTHFR
(pCAS30)
[34]

SHMT
(pBSGlyA)
[77-79]

Primer sequences with the introduced restriction enzyme
sequence underlined
5’TATTTACATATGAGCTTTTTTCACGCCAGC 3’ (NdeI)
Tm= 56oC, 30 mer with 22 complementary bases (forward
primer)
5’AAGGGGTTATGCTAGTTATTGCTCA 3’
Tm= 56oC, 25 bp complementary sequence (reverse primer)
5’GGGAGGAGGCATATGTTAAAGCGTGAAATGAACAT
TGCCGATTATGATGCC 3’ (NdeI)
Tm= 64 oC, 51 mer with 39 complementary bases (forward
primer)
5’GAGAGAGAGCTCGAGTGCGTAAACCGGGTAACGTG
C 3’ (XhoI)
Tm= 56oC, 36 mer with 20 complementary bases (reverse
primer)

Annealing
Temperature
( 0 C)
51 oC

50 oC

2.3.4 TOPO TA cloning: Cloning the PCR product into the TOPO TA vector pCR®2.1
Following PCR amplification, the PCR products of metF and glyA were cleaned with the
Gene JET PCR Purification Kit (Thermo Scientific) following the manufacturers protocol. The
resulting PCR products were cloned into the pCR 2.1 vector based on the Taq DNA polymerase
reaction. This polymerase provides A-overhangs on the PCR fragment which allows ready ligation
with the TOPO TA kit (Invitrogen). The resulting ligation mixture was transformed into Top10
One Shot chemically competent listed in Table 2-1 (above) [66] using a standard heat shock
method and 20 µL and 50 µL aliquots were plated on YT agar media with 50 µg /ml kanamycin
to select for cells carrying the TOPO vector.

40 µg/mI 5-bromo-4-chloro-3-indolyl-β-D-

galactopyranoside (X-gal) was added to select for colonies carrying the vector with the insert using
a white/blue colony selection. The plates were incubated overnight at 37°C. After overnight cell
growth, ten white colonies were selected and grown in YT broth with 200 µg/mL ampicillin. The
plasmid DNA was extracted using the Wizard Miniprep DNA purification system and the identity
of the insert was confirmed by DNA sequencing.
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2.3.5 Sample cleaning processes: Preparing the insert and vector DNA fragments for cloning.
The plasmid DNA for each clone and the pKTS vector were linearized with NdeI and XhoI
following the manufacturer’s protocol with minor modifications. Briefly, the restriction enzyme
digest was performed in a 20 µL volume containing 1-2 µg of DNA, 1X Cutsmart™ buffer (50
mM potassium acetate, 20 mM Tris-acetate, 10 mM magnesium acetate, and 100 µg/mL BSA pH
7.9 g) with 5 to 10 units of NdeI (NEB) and XhoI (NEB). Then the samples were incubated at 37
o

C from 3 hours to overnight. The digested DNA samples were electrophoresed on a 1% SeaKem®

LE agarose (Rockland, ME) gel using modified Tris-acetate EDTA (TAE) buffer (1 mM
NaEDTA,40 mM Tris acetate, pH 8). The DNA fragments were visualized by staining the gel
with 0.5 µg ethidium bromide/ ml (Sigma). The correct sized DNA fragments were determined
under a long wave UV light using a 1 kb plus DNA ladder as a standard. Then, the correct DNA
fragment, based on the fragment size, was excised and purified with the Ultrafree®-DA and
Wizard clean up systems (Millipore) according to the manufacturer’s protocol. The desired DNA
fragments were precipitated with 7.5 M ammonium acetate plus ethanol and suspended with
filtered (0. 22 µm syringe filter, Millipore) and autoclaved Milli-Q Water. The DNA concentration
was estimated with the NanoDrop 1000 Spectrophotometer (Thermo Scientific). The insert:vector
ratio was calculated using Equation 1.

ng of insert =

ng vector × kb size of inset
insert
× molar ratio of
kb size of vector
vector
Equation 1

2.3.6 Ligation and transformation
Linearized and cleaned DNA fragments were cloned using the DNA Ligation System
Ver.2.1 kit (Takara Bio Inc.) following the manufacturer’s instructions. Briefly, the insert and
vector DNA molecules were mixed in a 1:1, 1:3, and 1:5 ratio and equal volumes of Solution 1
(Takara Bio Inc.) were added. The samples were incubated overnight at 16 0C. Next, the ligation
mixture was divided into two parts. The first half of the DNA mixture was directly transformed
into chemically competent cells of the appropriate knockout strains. The other half of the ligated
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DNA was precipitated with 7.5 M ammonium acetate plus ethanol and resuspended with 10 µL
filtered (0. 22 µm syringes filter, Millipore) and autoclaved Milli-Q Water for electroporation.
Chemically competent cells of knockout E. coli strains were made and the ligation mixture
was transformed as described above. Electroporation was performed on electrocompetent cells
following the manufacturers protocol (Bio Rad). Briefly, 1- 4 µL of ligated and precipitated DNA
mixture was mixed with 40 µL electrocompetent cells and gently mixed. The cell suspension was
transferred into an electroporation cuvette of 1 mm inter-electrode gap (BTX Technologies Inc.
Hawthorne, NY). Electroporation was performed by a single pulse at the setting 1 E.C that
corresponds to 1.8 kV. The sample preparation and set-up of cuvettes, plasmid DNA and
electrocompetent cells were kept on ice. Immediately after electroporation, 1 ml of S.O.C. media
was added to the electroporation cuvette and the cells were transferred into a sterile 1.5 mL
Eppendorf tube. The mixture was shaken at ~200 rpm at 37 oC for one to three hours. ~ 50 µL and
100 µL cells were plated as described below.
To identify the correct clones, the selection used the ability of the clone to rescue the
knockout host strain to prototrophy.

The plates were Bonner-Vogel (BV) minimal media

containing 1xBV salt: 0.00038 M MgSO4.7H2O, 0.0094 M citric acid•H2O, 0.0574 M K2HPO4,
0.0167 M NH4NaHPO4•4H2O), 0.2% glucose/mL, 50.0 μg histidine/mL, 40.0 μg guanine/mL,
50.0 μg tyrosine/mL 50.0 μg tryptophan/mL, and 1.0 µM thiamine. An alternate selection used
YT agar media with selective antibiotic. The former selection is based on the ability of the clones
to rescue the host to prototrophy and the latter selection allows for the antibiotic resistance
selection associated with the pKTS vector. The E. coli LH18 strain carrying the DHFR clone was
selected on BV minimal media consisting of BV minimal media plus 50.0 μg thymidine/mL. The
correct clones were further verified by DNA sequencing.
2.4

Tetracycline titration
To assess the ability of the folate pathway gene carried in pKTS to rescue the appropriate

knockout strain from auxotrophy, the optimal tetracycline concentration that supports a minimal
but confluent cell growth was determined by streaking an overnight cell culture on plates
containing increasing concentrations of tetracycline. The concentration range used was 0 (no
tetracycline, control), 10 ng tetracycline/ml, 25 ng tetracycline/ml, 50 tetracycline/ml, 75 ng
tetracycline/ml, 100 ng tetracycline/ml, 200 ng tetracycline/ml and 500 ng tetracycline/ml ng
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tetracycline/ml in either M9 minimal media or Bonner-Vogel (BV) minimal media. The
tetracycline concentration that supports confluent cell growth was determined.

Table 2-5 The folate end products added as supplement(s) to BV minimal media
Gene

Folate end product supplement

folA

30.3 μg adenine /mL, 50.0 μg glycine /mL, 50.0 μg methionine/mL and 10.0 μg
pantothenate/mL

glyA

50.0 μg glycine /mL and 50.0 μg serine /mL

metF

50.0 μg methionine/mL

folP

50.0 μg thymidine/mL

folC

50.0 μg glycine /mL and 50.0 methionine μg /mL,

2.5

Sorbitol titration
Effects of osmotic stress on the in vivo activities of folate pathway enzymes.
E.coli knockout strains carrying the appropriate folate enzyme cloned in pKTS were plated

on BV minimal agar with the optimal tetracycline concentration that supported confluent bacterial
growth. Then, a sorbitol titration (0 to 1.50 M) was performed to determine if increasing in vivo
osmolality can interfere with the ability of the enzyme to rescue the host cell to prototrophy.
A positive control involved plating the cells on BV supplemented media.

This allows

discrimination between the lack of cell growth due to loss of free water in the cell from the effect
of osmolytes on enzyme activity [85]. Folate end product(s) supplements for each enzyme are
listed in Table 2-5 (above).
2.5.1 Quantifying osmolality of a media
Water activity measurements: The water activity of BV agar containing 0, 0.25, 0.50, 0.75,
1.00, 1.25 or 1.05 M of sorbitol was measured at room temperature using an AquaLab dew point
water activity meter 4TE (Decagon Devices, Inc., Pullman, WA). Then, the osmolality (Osm) was
calculated using Equation 2.

Osmolality (Osm) =

ln aH2O
−0.018

Equation 2
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2.6

Effects of osmolality on the ability of plasmid encoded R67 DHFR and/or Quad4 to rescue
E. coli from TMP pressure
The activity of EcDHFR is inhibited by trimethoprim (TMP) (Ki = 20 pM) [18], but R67

DHFR provides resistance to this drug (Ki = 0.15 mM) [19]. Thus, the activity of R67 DHFR and
Quad4 in the presence of increasing osmolality was assessed by the ability of the clones to allow
DH5α to grow on M9 media containing 200 µg ampicillin/mL, 20 µg TMP/mL, 100 ng
tetracycline, and various concentrations of sorbitol (0 to 1.50 M). The plates were incubated at 37
0

C and the cell growth was observed for 2 to 5 days. As a control to evaluate the optimal external

osmotic pressure that blocked DH5α growth, cells were grown on M9 media titrated with sorbitol,
but without antibiotics.
2.7

Effects of osmolality on the activity of folylpolyglutamate synthase (FPGS)
The effect of osmolality on the function of FPGS was assayed in the E. coli SF2 strain (F-

folC strA). The FolC chromosomal lesion carries a G925A mutation corresponding to an A309T
mutation in FPGS [49, 50]. This strain is auxotrophic for methionine and its growth is stimulated
by glycine [49]. Thus, the activity of FPGS in the presence of increasing osmolality was assessed
by the ability of the pAC3, pAC5 and pPM103-FolC plasmids (see Table 2-2 above) to rescue E.
coli SF2 (F- folC strA) from methionine and/or glycine auxotrophy on BV minimal media lacking
these components. Cell growth was compared to that of the E. coli SF2 parent strain E. coli
MG1665.
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CHAPTER: 3

Chapter 3 : Results
3

Results
We propose that increased osmolality will titrate the activity of folate pathway enzymes due

to preferential interactions of osmolytes with the various folate redox states. This hypothesis can
be probed genetically via restoration of prototrophy to the appropriate knockout strains. A
challenge to this approach is controlling the enzyme turnover rate and/or protein production level
[1, 4]. To address these issues, the gene for the enzyme of interest was cloned into a controllable
pKTS vector [4]. This plasmid was transformed into the appropriate E. coli knockout strain and
osmotic stress titrations were performed.
3.1

Assessing the activity of R67 DHFR and/or Quad4 clones in the presence of increasing
osmolality in vivo
Our first gene of interest was R67 DHFR. This target was selected as we previously

performed osmotic stress titrations of the Y69L mutant clone [1]. At that time, the activity of the
wt R67 DHFR clone was too high to titrate in vivo. To decrease the activity of the enzyme as well
as the protein life time, our first step was cloning the R67 DHFR gene into the pKTS plasmid. An
additional tandem array of 4 fused R67 DHFR genes (named Quad4) was also cloned into pKTS.
3.1.1 Construction of R67 DHFR-pKTS and Quad4-pKTS
The pKTS vector has NdeI and XhoI cloning sites for gene insertion [4]. This vector was
sent to us with a chorismate mutase insert. To facilitate cloning of R67 DHFR and Quad4 genes
into pKTS, synthetic genes with NdeI and XhoI restriction enzyme recognition sequences at the
5’ and 3’ ends of the genes were synthesized by GenScript. These constructs were purchased as
clones in the pUC57 vector. Prior to constructing the desired plasmids, the R67 DHFR-pUC57,
Quad4-pUC57, and chorismate mutase-pKTS DNA minipreps were transformed into DH5α and
colonies were selected on YT agar media with 200 μg ampicillin/ml. Four to six colonies were
grown in YT liquid media with 200 μg ampicillin/ml. Next, the plasmid DNA of individual
colonies was extracted and the DNA sequences were confirmed via DNA sequencing.
Then, the plasmid DNA encoding R67 DHFR, Quad4, and pKTS was double digested
with NdeI and XhoI. As can be seen in Figure 3-1 (below), the DNA was separated on a 1%
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agarose gel, which also removed the restriction enzymes. The correct sized DNA fragments for
the R67 DHFR or/and Quad4 genes were excised from the gel, cleaned and ligated into pKTS.
The ligation mixture was transformed into E. coli DH5α and plated on YT agar media with 200
μg ampicillin/ml. After overnight cell growth, single colonies were inoculated into YT broth with
200 μg/ml ampicillin. After overnight cell growth, the plasmid DNA was extracted and the R67
DHFR-pKTS or/and Quad4-pKTS clones were verified by sequencing.

Figure 3-1 Restriction enzyme digested DNA encoding R67 DHFR-pUC57, chorismate
mutase-pKTS and Quad4-pUC57
Lane 2: uncut R67 DHFR-pUC57, Lanes 3 and 4: NdeI and XhoI digested R67 clone,
insert size = 273bp. Lane7: uncut chorismate mutase-pKTS, Lanes 8 and 9: NdeI and XhoI
digested chorismate mutase-pKTS (vector size 3,321 bp). Lanes 12 and 13: NdeI and XhoI
digested Quad4-pUC75 clone, insert size 1,085 bp, Lane14 uncut Quad4-pKTS. The DNA
samples were separated on a 1% agarose gel. DNA ladders are also shown in lanes 6 and
11 (100 bp and 1000 bp plus, respectively). Brackets show the bands used in cloning.
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3.2

Tetracycline dependent E. coli DH5α and/or E. coli LH-18 (ΔFolA::Kan) growth on M9
and/or Bonner-Vogel minimal selective media

3.2.1 Identification of the tetracycline concentration required to produce sufficient in vivo R67
DHFR and/or Quad4 to confer TMP resistance upon E. coli DH5α.
To determine the minimum tetracycline concentration required to obtain confluent cell
growth of DH5α carrying R67 DHFR-pKTS and/or Quad4-pKTS, cells were plated on M9
minimal media without antibiotics (control) or with 200 μg ampicillin/ml, 20 μg/ml TMP and
various concentrations of tetracycline/ml (e.g. 0, 10, 25, 50, 75, 100, 200 and 500 ng/ml). The
growth of the streaks on each plate was examined for three days (the third day plate images are
shown in Figure 3-2 (below). After 24 hours, confluent cell growth was observed on the M9
minimal plate without antibiotic. Also E.coli DH5α carrying R67 DHFR-pKTS and/or Quad4pKTS showed incremental cell growth that correlates with the tetracycline concentration added to
induce expression from the Ptet promoter. As can be seen in Figure 1-2 (below) cells carrying the
R67 DHFR-pKTS clone showed confluent cell growth at 50 ng tetracycline/ml, while Quad4pKTS showed confluent cell growth at 10 ng tetracycline/ml. The need for a slightly higher
concentration of tetracycline for a confluent growth in the R67 DHFR-pKTS clone is likely related
to four SsrA tags associated with tetrameric R67 DHFR vs. one SsrA tag associated with
monomeric Quad4.
3.2.2 Identification of the tetracycline concentration required to induce sufficient R67 DHFR
and/or Quad4 production to allow confluent growth of E. coli LH-18 (ΔFolA::Kan) on
Bonner-Vogel minimal media.
Prior to performing a tetracycline titration, we evaluated the growth pattern of the E. coli
LH-18 (∆folA::kan) strain which is auxotrophic for folate end products [63]. The cells were grown
in YT and/or glucose liquid media with 20 µg kanamycin /ml plus 50 µg thymidine /ml. The next
day, cells were streaked on Bonner-Vogel (BV) minimal agar supplemented with folate end
products (30 μg adenine/ml, 10 μg pantothenate/ml, 50 μg glycine/ml, and 50 μg methionine/ml)
[63]. Kanamycin (25 μg/ml) was also added to select for the deletant strain. Cells were additionally
plated on BV minimal media (lacking the folate end product supplements) plus kanamycin. The
plates were incubated at 37 oC. As can be seen at 24 hours in Figure 3-3 (below), cell growth was
observed on BV supplemented media, but not on BV minimal media. The results are consistent
with previous studies that this strain is auxotrophic for folate end products [63].
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Figure 3-2 Tetracycline dependent E. coli DH5α growth on M9 media.
The plate in the upper left panel contains no antibiotics. The other plates contain 20 g
TMP/ml. The optimal tetracycline concentration required to induce the Ptet promoter to produce
sufficient DHFR activity to support confluent cell growth was determined from the tetracycline
dependent cell growth pattern of E. coli DH5α carrying R67 DHFR-pKTS and Quad4-pKTS.
The cartoon in the lower right shows how the constructs are streaked on the plates.
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Figure 3-3 Growth pattern of E. coli LH-18 in BV supplemented (A) and minimal (B) media.
E. coli LH-18 cells grew in BV supplemented media but not the minimal media. The 48 hour
plate image is shown.
To determine the minimum tetracycline concentration required to obtain confluent growth
of E. coli LH-18 carrying R67 DHFR–pKTS or Quad4-pKTS, cells were plated on BV minimal
media with 25 μg kanamycin/ml, 200 μg ampicillin/ml, and various concentrations of
tetracycline/ml (10, 25, 50, 75, 100, 200 and 500 ng/ml ng/ml). The plates were examined for three
days. As can be seen from the third day image Figure 3-4 (below), the growth of E. coli LH-18
carrying R67 DHFR-pKTS or Quad4-pKTS reflects an incremental cell growth that correlates with
the tetracycline concentration. The R67 DHFR clone supported confluent LH-18 growth with 50
to 200 ng tetracycline/ml. On the other hand, Quad4 supported confluent cell growth from 10 up
to 200 ng tetracycline/ml. As can be seen inFigure 3-2 (above), a similar cell growth pattern was
observed for the TMP resistance titration performed in DH5α. These results suggest that titration
of TMP resistance or of restoration of prototrophy to an auxotrophic strain are related and both
depend on the level of R67 DHFR activity present.
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3.2.3 Effect of osmolality on the ability of the R67 DHFR and/or Quad4 clones to provide
TMP resistance to E.coli DH5α
External osmotic stress causes cytoplasmic water loss, which can slow and eventually
cause bacterial growth to cease [17]. To examine the effect of increasing external osmotic
pressure on E. coli DH5α, cells were plated on M9 media without antibiotic and the following
osmolalities: 0.54, 0.79, 1.07, 1.28, 1.64, 1.90, and 2.42 Osm. Osmolality was increased via
addition of exogenous sorbitol. This set of plates was used to determine the osmotic fitness of
DH5α. As can be seen inFigure 3-5(below), DH5α growth decreased at 1.90 Osm and
completely stopped at 2.42 Osm. At this level of osmotic stress, the bacteria were unable to grow
due to loss of free water in the cell somewhere between 1.90 Osm and 2.42 Osm. This is similar
to the observation of Cayley et al. where E. coli growth stopped at ~ 1.95 Osm [85, 86].
To assess the effect of increasing in vivo osmolality on the function of R67 DHFR and/or
Quad4, E.coli DH5α carrying R67 DHFR-pKTS and/or Quad4-pKTS clones were plated on M9
minimal media with 200 μg ampicillin/ml and 20 μg TMP/ml, while the in vivo protein production
was controlled with 100 ng tetracycline/ml. The external osmolality was increased by addition of
0 to 1.50 M of sorbitol in 0.25 M increments. The osmolalities of the M9 plates without added
sorbitol were 0.45 Osm and 0.50 Osm. The osmolalities of the plates with added sorbitol were
0.78, 0.81, 1.28, 1.60, 1.93, and 2.23 Osm. As can be seen in Figure 3-6(below), R67 DHFR
production rescued DH5α on 0.78, 0.81 and 1.28 Osm plates, but the cell growth was sparse under
1.28 Osm and stopped at ≥ 1.60 Osm. On the other hand, Quad4 provided sufficient DHFR activity
to allow confluent growth of DH5α under 0.78, 0.81, 1.28, and 1.60 Osm, and totally stopped at
1.93 Osm. The lesser efficiency of the R67 DHFR clone to allow growth could be explained by a
lower protein stability/life time which derives from its homo-tetrameric structure. The
homotetramer will have 4x more SsrA tags as compared to monomeric Quad4 which carries only
1X SsrA tag.
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Figure 3-4 Tetracycline dependent growth of E. coli LH-18 on BV minimal media
The optimal tetracycline concentration required to induce the Ptet promoter to support confluent
cell growth was determined on BV minimal media containing 200 μg ampicillin/ml, 25 μg/ml
kanamycin and various concentrations of tetracycline. The cartoon on the lower right shows how
the constructs are streaked on the plates.
To assess the effects of osmolytes on the ability of R67 DHFR and/or Quad4 to rescue the
host cell from TMP resistance, it is important to evaluate the effect of increasing osmolyte
concentrations on the viability of the cells. This was achieved by comparing the growth patterns
of control and test plates seen in Figure 3-5 and Figure 3-6 (below). On the control plates, DH5α
stopped growing somewhere between 1.90 Osm and 2.43 Osm. However the R67 DHFR clone
stopped growing between 1.28 Osm and 1.60 Osm while the Quad4 clone stopped growing
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between 1.60 Osm and 1.93 Osm. In both cases the bacteria ceased growth at a lower osmolality
than the control. Considering our lab’s previous in vitro observation [23], the loss of activity of
both R67 DHFR and Quad4 could be due to the preferential interactions of osmolytes with DHF
which weakens binding and results in loss of sufficient DHFR activity to rescue the cell.
3.2.4 Effect of osmolality on the ability of R67 DHFR and/or Quad4-pKTS clones to rescue
E.coli LH-18 to prototrophy
Our first set of cell growth assays assessed how increasing in vivo osmolality affected the
ability of R67 DHFR and/or Quad4 to provide TMP resistance to DH5α. To test our hypothesis
directly on the activity of DHFR, we used E. coli LH18 (ΔfolA::kan). For LH-18 to grow, it
either requires addition of folate end products into the media or should be complemented with a
functional DHFR gene [63].
The first set of cell growth assays aimed to assess the osmotic fitness of LH-18 on BV
supplemented media containing 25 µg kanamycin/ml and increasing osmolalities of 0.78, 1.06,
1.34, 1.50, 2.12, and 2.32 Osm. As can be seen in Figure 3-7 (below),LH-18, with and without the
plasmid, had similar confluent growth patterns from 0.77 Osm to 1.50 Osm. The growth was more
sparse at 1.50 Osm, and growth stopped on the plates with ≥ 2.12 Osm. These observations
suggested that the bacterium no longer had free cytoplasmic water and ceased to grow. Next, to
probe the effects of increased osmolality on DHFR activity supplied by the R67 DHFR and/or
Quad4-pKTS clones, external osmotic stress was applied to LH-18. The osmolality of a series of
plates was 0.52, 0.85, 1.04, 1.37, 1.68, 2.10, and 2.23 Osm. As can be seen in Figure 3-8 (below)the
R67 DHFR clone rescued LH-18 on BV minimal plates with 0.50, 0.85, and 1.04 Osm, however
cell growth on the 1.04 Osm plate was sparse, and growth was not observed on 1.37 Osm plate.
Further, Quad4-rescued LH-18 under 0.50, 0.85, 1.04, 1.37 and 1.68 Osm, growth was stopped
2.10 Osm. Confluent cell growth was observed on the first four plates, but cell growth on the 1.68
Osm plate was sparse.
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Figure 3-5 Effect of osmolality on E. coli DH5α viability.
An assessment of the ability of E. coli DH5α carrying R67 DHFR-pKTS or/and Quad4-pKTS
to grow in the presence of increasing concentrations of sorbitol. The cells were plated on M9
minimal medium without antibiotics and different concentrations of sorbitol were added.
Confluent growth was observed up to 1.90 Osm, cell growth stopped on the 2.43 Osm plate,
suggesting the bacteria ceased growing due to free water loss. The lower right cartoon shows
the pattern of cells streaked on the plates
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Figure 3-6 Effect of osmolality on the ability of R67 DHFR and/or Quad4 clones to rescue
DH5α from TMP resistance.
The ability of R67 DHFR and/or Quad4 clones to provide TMP resistance to DH5α on M9
minimal media with 200 μg ampicillin/ml, 20 μg TMP/ml and without tetracycline (top first
image) and 100 ng tetracycline/ml was assessed on media with osmolalities from 0.45 to 2.30
Osm. The R67 DHFR clone supported confluent E. coli DH5α growth on M9 agar media with
0.5, 0.78, and 0.81 Osm. On the other hand, the Quad4-pKTS clone supported confluent E.
coli DH5α growth on M9 media with 0.5, 0.78, 0.81, 1.28, and 1.60 Osm. Both R67 DHFR
and Quad4 were not able to rescue DHSα from TMP pressure in the absence of tetracycline.
The lower right cartoon shows how various cultures were streaked on the plates.
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As described above, two different aspects of DHFR activity were assessed, i.e. the ability
to confer TMP resistance upon host bacteria and to rescue a DHFR knockout strain from folate
end product auxotrophy. As can be seen from (Figure 3-6, and Figure 3-8 below), both of these
assays showed sensitivity to increasing osmotic stress with loss of cell growth under high
osmolalities. The control titrations with media lacking TMP or with supplemented media (Figure
3-5 and Figure 3-7 below) indicate that the cells can grow to higher osmolality. This difference in
growth pattern suggests that DHFR activity can be titrated in vivo. These observations are also
consistent with the in vitro assays of Chopra et al. [1] where addition of osmolytes weakens binding
of substrate to DHFR and decreases the overall activity of the enzyme under limiting substrate
conditions.
3.3

Can osmotic stress affect the in vivo activity of the folC gene product, FPGS?
To continue probing our hypothesis that osmolytes will interact with many folate redox states

and shift the equilibria towards the free species, we next examine the effect of increasing
osmolality on the function of folylpolyglutamate synthase (FPGS), the product of the folC gene.
This enzyme adds L-glutamate to dihydropteroate; it also extends the glutamate tail of THF using
a γ-linkage. Both THF and 10-formyl-THF are FPGS substrates [35].
3.3.1 E. coli: SF2 (F- folC strA,) a mutant strain with a lower activity of FPGS
A previous study by the Bognar lab has reported two mutant folC strains of E. coli: SF2 (FfolC strA) and SF4 (F- folC strA recA TnI0:srlC) [50]. These strains carry a G925A mutation in
the folC chromosomal gene [50] that corresponds to an A309T amino acid change in the protein.
This mutant protein displays a 30 fold increase in KM for 10-CHO-THF, a 60 fold increase in the
KM for glutamate, a 10 fold increase in the KM for ATP and a 200 fold increase in the KM for
dihydropteroate [49, 50]. The reduced FPGS activity results in the absolute requirement for
methionine in the growth media; added glycine further increases the growth rate [49]. Since the
activity of this mutant strain is already compromised, we asked if the FPGS activity of the SF2
strain could be titrated by osmotic pressure.
The parent strain of SF2, known as MG1655, grew on both BV minimal and supplemented
plates without and with complementation. SF2 grew on BV supplemented plates, but not on BV
minimal plates as shown in Figure 3-9 (below) where SF2 carrying a functional folC gene in trans
grows on both BV minimal and supplemented plates suggesting the FPGS activity of the clones
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rescues SF2 to prototrophy. Several different FPGS containing plasmids were used, pAC5 and
pPM103 [50] (see Table 2 in the Methods section). Similar growth patterns of the parent strain
with and without the folC clone suggested multiple copies of folC are not detrimental to the cells.

Figure 3-7 Effect of osmolality on E. coli LH-18 viability.
The ability of E. coli LH-18, and this strain carrying R67 DHFR-pKTS or/and Quad4pKTS clones to grow in the presence of increasing concentrations of sorbitol was assessed
on BV supplemented media. Added folate end products are 3.03 mg adenine /ml, 1.0 mg
pantothenate/ml, and 50 µg glycine /ml with 50 μg thymidine/ml. A further 25 µg
kanamycin/ml was added to select for the ΔfolA::kan lesion. Sorbitol addition led to
plates possessing osmolalities of 0.55, 0.77, 1.06, 1.34, 1.50, 2.12, and 2.32 Osm.
Confluent bacterial growth was observed until 1.50 Osm. E. coli LH-18 did not grow on
BV supplemented plates with an osmolality of ≥ 2.12 Osm, suggesting no free
cytoplasmic water was present which blocked cell growth. The lower right cartoon shows
how the various cultures were streaked on the plates.
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Figure 3-8 Effect of osmolality on R67 DHFR and/or Quad4 activity on BV minimal plates.
The ability of R67 DHFR or/and Quad4-pKTS clones to rescue LH-18 from folate end
product auxotrophy was assessed on BV minimal media containing 200 μg ampicillin/ml, 25
µg kanamycin/ml, 100 ng tetracycline/ml and sorbitol additions such that the osmolality was
0.52, 0.85, 1.04, 1.37, 1.68, 2.10, and 2.23 Osm. The R67 DHFR-pKTS clone rescued LH-18
on BV minimal plates with 0.50, 0.85, and 1.04 Osm, however cell growth on the 1.04 Osm
plate was sparse. The Quad4-pKTS clone rescued LH-18 on BV minimal plate possessing
osmolalities of 0.50, 0.85, 1.04, 1.37 or 1.68 Osm. The lower right cartoon shows how the
various cultures were streaked on the plates.
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Figure 3-9 The growth pattern of the folC mutant strain, SF2, and its parent strain MG1655.
Panel A shows their growth patterns on BV minimal agar while panel B shows their growth on
a BV plate supplemented with 50 μg methionine/ml and 50 μg glycine/ml. SF2 did not grow
on BV minimal media. However, both SF2 carrying a functional folC gene and the parent
strain grew on BV minimal and supplemented plates. The middle panel shows how the various
cultures were streaked on the plates.

3.3.2 Effect of osmolality on the function of folC
Osmotic stress effects on the growth of the SF2 strain on BV media supplemented with
excess methionine and glycine
Next, we asked if an increasing in vivo osmolality could impact the ability of the SF2
strain to grow on BV supplemented media; i.e. if osmolytes weakly interact with dihydropteroate
and/or tetrahydrofolate based substrates, this can weaken their binding to FPGS and potentially
titrate the activity of the A309T mutant enzyme. Since loss of FPGS activity is lethal to the cell
[69], this could block cell growth. This hypothesis was tested by plating SF2 and SF2 carrying
pAC5 and/or pPM103-FolC plasmids as well as the MG1655 parent strain without and with the
pAC5 and/or pPM103-FolC plasmids on BV media supplemented with 50 μg methionine/mL and
50 μg glycine/mL. The osmolality of the media was gradually increased via sorbitol in 0.25 M
increments from 0 to 1.50 M. Also to stimulate FPGS protein synthesis that is controlled by the
Lac promoter in the pAC5 plasmid, 1 mM IPTG was added. As seen in Figure 3-10 (below) the
MG1655 strain carrying either the pAC5 or pPM103-folC plasmid allowed confluent growth on
media containing up to 1.25 M sorbitol. Cell growth ceased on 1.50 M sorbitol. On the other hand,
SF2 and SF2 carrying either pAC5 or pPM103-FolC plasmids grew confluently up to 0.75 M
sorbitol and decreased in the presence of 1.00 M sorbitol, and completely stopped on a 1.25 M
sorbitol Figure 3-10 (below).
56

The differences in cell growth patterns between the parent strain and SF2 carrying a
functional folC in Figure 3-10 (below) were unexpected. If the difference between the parent
strain and SF2 is only a A309T mutation in the folC gene, we assumed the wild type clone would
complement the lost activity and allow similar growth as the parent strain under higher osmotic
stress.

Figure 3-10 The effect of increasing osmolality on the growth of E. coli SF2.
The effect of increasing osmolality on the growth of SF2 with and without complementation was
assessed. All cultures were streaked on BV minimal media supplemented with 50 μg
methionine/mL and 50 μg glycine/mL with various concentrations of sorbitol (0.25 M, 0.50 M,
0.75 M, 1.00 M, 1.25 M or 1.50 M). The right panel shows how the various cultures were
streaked on the plates.
Growth of the SF2 strain on BV media supplemented with a sub-optimal concentration of
methionine
In another series of experiments, we asked if decreasing the methionine and/or glycine
concentration from an optimal level would increase the pressure on the enzyme to function under
increasing osmotic pressure and allow a titration of FPGS activity. For the first trial, since
methionine is absolutely required for SF2 growth [49], the optimal methionine concentration
methionine was determined by titrating different concentrations of methionine ranging from 0 to
50 µg /ml. Minimal growth of SF2 was observed on a BV media supplemented with 7.46 µg
methionine /ml (data not shown). Then, the activity of SF2 under increasing osmolality was
assessed by plating various cultures on BV media supplemented with only 7.46 µg methionine /ml
and 50 µg glycine/ml. Interestingly, the cell growth patterns of the parent strain and the parent
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strain carrying three different plasmid were able to show confluent growth up to 1.25 M sorbitol
plate.. The cell growth was slightly decreased under 1.50 M plates (see Figure 3-11 (below)) On
the other hand, SF2 with and without complementation showed confluent growth up to 1.00 M
sorbitol and the cell growth was decreased under 1.25 M and stopped on 1.50 M plate, while SF2
growth showed slight improvement from Figure 3-11 (below). Minimizing the methionine
concentration did not allow titration of SF2 growth by osmotic stress as compared to MG1655.
These results suggested that other mutations may be present in the SF2 strain to make it more
sensitive to osmotic stress. As SF2 was created by treating MG1655 with ethylmethane sulfonate
[49], this seems a likely possibility. Our inability to titrate FPGS activity by osmotic stress
indicates either that FPGS is not sensitive to osmotic pressure or that the FPGS activity is still
sufficient to rescue the cell.
3.4

Cloning the Methylenetetrahydrofolate Reductase (MTHFR) gene (metF) into pKTS
Next, to continue probing the effect of osmolality on the activity of folate enzymes, MTHFR

was selected. This enzyme reduces 5, 10-methylene-THF to 5-methyl-THF using NAD(P)H as a
cofactor [34, 51]. If osmolytes weakly interact with 5, 10-methylene-THF, the in vivo activity of
MTHFR can be titrated and assessed by its ability to rescue a knockout to prototrophy. This section
describes how a metF-pKTS construct was made, the auxotrophy of the E. coli JW39131 (∆metF::kan) strain was tested and the tetracycline dependent growth characteristics of JW39131 carrying metF-pKTS was assessed. Additional experiments are ongoing in the lab to determine
the effect of increasing concentration of osmolytes on the activity of MTHFR by the ability of the
metF-pKTS clone to rescue E. coli JW3913-1 (∆metF::kan) to prototrophy.
3.4.1 Designing a primer, PCR amplification and cloning into the pCR 2.1 TOPO TA vector
A clone of the MTHFR gene was a gift from Dr. Elizabeth Trimmer from Grinnell College.
Her pCAS-30 clone is a derivative of the pET2-3b plasmid [34]. To assess the quality of the DNA
and cloning sites of the gene, the plasmid was transformed, selected and sequenced with T7 and
T7 terminator primers. The sequence alignment results showed the metF open reading frame was
cloned between XbaI and XhoI sites. A sequence encoding a C-terminal His6 tag was present. To
introduce an NdeI restriction sequence via PCR, a forward primer that adds a NdeI restriction
sequence was used along with a primer near the T7 terminator site. Primers were designed as
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described in the Material and Methods section of this thesis (Table 5). The primers were
synthesized by Invitrogen, Carlsbad, CA.

Figure 3-11 Assessing the effect of osmolality on SF2 growth with a sub-optimal level of
methionine.
The ability of SF2 to grow in the presence of a sub-optimal methionine concentration.
of 7.46 µg methionine/ml and 50 μg glycine/ml and various concentrations of sorbitol
(0.25 M, 0.50 M, 0.75 M, 1.00 M, 1.25 M or 1.50 M) and 1 mM IPTG was assessed. The
bottom right panel shows how the various cultures were streaked on the plates.
Next, for the purpose of adding an ‘A’ overhang into the PCR product of metF which would
enable cloning into the TOPO TA pCR 2.1 (Invitrogen), Taq polymerase was used [87]. The PCR
product is shown in Figure 3-12 (below). The PCR product was cleaned with the GeneJET PCR
Purification Kit (Thermo Scientific), cloned into the TOPO TA vector and transformed into TOP10
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E. coli cells. The cell suspension was plated on YT agar with 50 µg kanamycin /ml. Use of the
X-gal blue/white colony [87] screening technique allowed selection of six white colonies carrying
a plasmid with an insert. These cells were individually grown in YT liquid media, and the plasmid
DNA was extracted and sequenced with M13 Forward and M13Reverse primers. A total of five
correct colonies were found.

Figure 3-12 PCR amplification of the metF gene.
An Nde1 restriction site was introduced at the 5’ end of the gene. The expected length of the
PCR product was 891 bp. The PCR product was electrophoresed on a 1% agarose gel. Lane
1:1Kb plus DNA ladder and Lanes 3 and 4: the PCR product of metF of expected size.
3.4.2 Construction of the metF-pKTS plasmid
To clone the metF gene into pKTS, a correct metF-pCR 2.1 clone and the pKTS-chorismate
mutase plasmid were double digested with NdeI and XhoI restriction enzymes. The DNAs were
separated on a 1% agarose gel (see Figure 3-13 (below)). The correct sized DNA fragments for the
60

metF gene and the pKTS plasmid were excised from the gel and ligated with T4 DNA ligase
(TaKaRa). The ligation mixture was transformed into the E. coli (∆metF::kan) strain. This strain
is auxotrophic for methionine, thus it will grow only on minimal media supplemented with
methionine or when complemented with a plasmid carrying a functional metF gene. The ligation
mixture was transformed into JW3913-1 (∆metF::kan) and the cells plated on either YT agar with
200 μg/ml ampicillin, 25 μg/ml kanamycin/ml and µg methionine/ml or BV minimal agar with
200 μg/ml ampicillin, 25 μg/ml kanamycin/ml and 80 ng/ml tetracycline. The next day, tiny
colonies started to appear on the YT plates and within 48 hours, colonies developed. On BV
minimal media, colonies started to appear after 48 hours. After 48 hours, six colonies from the YT
plate were selected and individually inoculated into YT broth with 200 μg/ml ampicillin. After
overnight growth, the plasmid DNA from six colonies was purified and the identity of the insert
was confirmed by DNA sequencing with T7 and T7 terminator primers. On the BV minimal plate
~ a total of 50 colonies were detected, suggesting the clone rescued JW3913-1 to prototrophy.
3.4.3 Assessing the growth pattern of E. coli JW3913-1 (∆metF::kan)
To characterize the growth pattern of E. coli JW3913-1 (∆metF::kan), the cells were grown
in YT liquid media with 25 μg kanamycin/mL and 50 µg methionine/ml. The next day, the cells
were plated on BV agar supplemented with 50 μg methionine /ml and 25 µg kanamycin/mL or BV
minimal media with 25 µg kanamycin/ml. The plates were checked for five consecutive days. Cell
growth was observed on BV supplemented media after 24 hours, but E. coli JW39131 (∆metF::kan) did not grow on BV minimal media. The image of the plate at 48 hrs is shown in
Figure 3-14 (below). This assay confirmed that E. coli JW3913-1 (∆metF::kan) is auxotrophic for
methionine.
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Figure 3-13 NdeI and XhoI digested metF-pCR 2.1 and pKTS.
Restriction enzyme digested metF-pCR 2.1 and pKTS-chorismate mutase. The plasmids were
digested with NdeI and XhoI and the DNA fragments were electrophoresed in a 1% agarose
gel. Lane1: metF-pCR 2.1, Lane3: 1,000 bp plus DNA ladder, Lanes 4 and 8: pKTS vector
with a chorismate mutase gene insert. The correct DNA fragments are shown by the arrow:
metF ~891 bp and pKTS ~3.9 kb.

Figure 3-14 The growth pattern of the metF knockout strain of E. coli JW3913-1.
Panel A shows growth of E. coli JW3913-1 (∆metF::kan) on BV supplemented media while
panel B shows no growth on BV minimal media.
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3.4.4 Identification of the tetracycline concentration required to induce sufficient MTHFR
production by metF-pKTS to rescue E. coli JW3913- (∆metF::kan)
To determine the minimum tetracycline concentration that will allow confluent cell growth
of E. coli JW3913-1 (∆metF::kan) carrying the metF-pKTS clone, several cell stocks were grown
in a YT liquid media with 200 μg ampicillin/ml and 25 μg kanamycin/ml. Next the cells were
plated on BV minimal media with 200 μg ampicillin/ml, 25 μg kanamycin/ml and various
concentrations of tetracycline (10, 25, 50, 75, 100, 200 and 500 ng/ml ng/ml). The plates were
examined for three days. After 18 hours, confluent cell growth was observed (the second day plate
images are shown in Figure 1-15 (below). Sparse cell growth was observed on BV media with no
tetracycline and 10 ng tetracycline/ml. Confluent growth was obtained on the plates with 25 to
200 ng tetracycline/ml. Cell growth became sparse on a 500 ng tetracycline/ml plate Figure 3-15
(below) suggesting 500 ng tetracycline/ml is cytotoxic to the host cell [88].

3.5

Initial experiments to explore the effect of in vivo osmotic stress on serine hydroxymethyl
transferase activity
The next folate pathway enzyme we considered was serine hydroxymethyl transferase

(SHMT). This enzyme is encoded by the glyA gene and the protein catalyzes the reversible
conversion of serine and tetrahydrofolate to glycine and 5,10-methylene tetrahydrofolate [37]. If
osmolytes preferentially interact with either THF and/or 5, 10-methylene tetrahydrofolate,
increasing the osmolyte concentration in vivo would weaken the catalytic efficiency of the enzyme.
To test this hypothesis, the glyA gene was cloned into pKTS. Experiments are ongoing in the lab
to determine the effect of increasing concentration of osmolytes on the activity of SHMT by the
ability of glyA-pKTS to rescue E. coli JW 2535-1 (Δgly::kan) to prototrophy.
Designing a primer, PCR amplification and cloning into the pCR 2.1 TOPO TA vector
We obtained the E. coli glyA gene cloned in the pBlueScript KS vector from Roberto
Contestible [77]. The DNA was transformed into E. coli DH5α and plated on YT agar with
ampicillin. After overnight growth, five colonies were selected and grown, and the plasmid DNA
was purified and sequenced with M13 Forward and M13 reverse primers. The open reading frame
of the glyA gene was cloned between PstI and BamHI cloning sites. To introduce NdeI and XhoI
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restriction sites via PCR, primers were designed. The primer sequences are given in the Materials
and Methods section. The primers were synthesized by Invitrogen (Carlsbad, CA).

Figure 3-15 Tetracycline dependent metF production
The tetracycline dependent growth of E. coli JW3913-1 (∆metF::kan) carrying the metFpKTS plasmid was monitored on BV minimal media. Confluent cell growth was observed at
concentrations ≥ 25 ng tetracycline/ml. The highest tetracycline concentration (500 ng/ml)
showed punctate growth, suggesting the concentration was too high. The bottom right panel
shows how the various cultures are streaked on the plates.
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Next, for the purpose of adding an ‘A’ overhang into the PCR product of glyA that would
enable cloning using the TOPO TA kit (Invitrogen), Taq polymerase was used. The PCR product
is shown in Figure 1-16 (below). The PCR product was cleaned with the GeneJET PCR
Purification Kit (Thermo Scientific), cloned into the TOPO TA vector and transformed into TOP10
E. coli cells. Half of the transformed cells were plated on YT agar with 50 µg kanamycin /ml.
The other half of the transformed cells was plated on agar containing X-gal and IPTG for
blue/white screening. Eight individual white clones were grown in YT liquid media, the plasmid
DNA extracted and the DNA sequenced with M13F/M13Rev primers. Five clones were identified
with a glyA insert.

Figure 3-16 glyA PCR product.
Introduction of Nde1 and Xho1 restriction enzyme sites into the glyA gene by PCR
amplification. The primer pair specific to glyA that enabled addition of NdeI and XhoI
sites was used to amplify the coding region of glyA (1,254 bp). The PCR product was
electrophoresed on a 1% agarose gel. Lanes 1 and 2: glyA PCR product and Lane 3:
1Kb plus DNA ladder. The PCR product appears in the position expected for its size.
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Construction of the glyA-pKTS plasmid
The next step was to digest the correct glyA-pCR2.1 clone with NdeI and XhoI and
separate the fragments on a 1% agarose gel see Figure 1-17 (below). The double digest of glyApCR2.1 revealed three bands. The top band was about 3.9 kb, which is the size of TOPO plasmid
pCR2.1 vector. The bottom two bands were approximately 900 bp and 300 bp. Assessment of the
glyA sequence found an internal XhoI site at 906 bp which suggested the ~ 900 bp and ~300 bp
fragments came from the glyA insert.

Figure 3-17 NdeI and XhoI digested glyA.
TOPO TA cloned glyA-pCR 2.1 was digested by NdeI and XhoI and separated on a 1% agarose
gel. Lanes 2 and 7: double digested glyA-pCR 2.1, Lane 4: 1 kb plus DNA ladder, and Lane 5:
uncut glyA-pCR 2.1. The double digested glyA-pCR 2.1 plasmid released ~3.9 bp, 900 bp and 300
bp fragments. The 3.9 bp fragment corresponded to the pCR 2.1 vector. However instead of the
expected ~1.2 bp glyA DNA fragment, ~ 900 bp and 300 bp fragments were detected. The lack of
the correct sized glyA fragment led to noticing the presence of an internal XhoI site at 906 bp
position that cut glyA into two fragments with ~ size 906 bp and 348 bp.
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Two commonly utilized techniques to obtain a complete DNA fragment from a vector
carrying multiple undesired restriction sites are partial digestion of the vector to obtain a full length
fragment and/or changing the undesired restriction enzyme recognition site via site specific
mutagenesis technique. For the latter method, codon redundancy could allow use of an alternative
DNA sequence which does not change the protein sequence.
After assessing our options, we elected to use the partial digestion protocol of Bloch and
Grossmann [89]. Briefly, ~ 9 µg glyA-pCR 2.1 plasmid DNA was re-suspended in 90 µL sterile
milli-Q H2O. Then, we added 1X CutSmart™ buffer (NEB) and 20 Unit/µl (2µl) of NdeI enzyme
and incubated the sample at 37 oC for 1 hour. After an hour, the sample was kept on ice and
transferred into five sterile eppendorf tubes labeled one to five with the following order and
volume: Tube1: 30 µL, Tube 2: 20 µL, Tube 3: 20 µL, Tube 4: 20 µL, and Tube 5: 10 µL. Next,
100 Units/µl (2 U/) of XhoI were added to the first tube and gently mixed. Then, 10 µL samples
were transferred, mixed and again a10 µL sample was transferred to the next tube. In other words,
a 10 µL sample was serially diluted until the 5th tube. Finally, the tubes were incubated at 37 oC
for 30 minutes. Immediately after removing the samples from the incubator, each sample was
loaded on a 1% agarose gel and separated. The electrophoresed DNA sample image is shown in
Figure 1-18 (below).
Construction of the glyA-pKTS plasmid
To clone the glyA gene into pKTS, a correct glyA-pCR 2.1 clone was partially double
digested and the pKTS-chorismate mutase plasmid were double digested with NdeI and XhoI
restriction enzymes. The DNAs were separated on a 1% agarose gel (see). The correct sized DNA
fragments for the glyA gene and the pKTS plasmid were excised from the gel and ligated with T4
DNA ligase (TaKaRa). The ligation mixture was transformed into the E. coli (∆glyA::kan) strain.
This strain is auxotrophic for glycine and serine, thus it will grow only on minimal media
supplemented with glycine and serisne or when complemented with a plasmid carrying a
functional glyA gene. The ligation mixture was transformed into JW2535-1 (∆glyA::kan) and the
cells plated on either YT agar with 200 μg/ml ampicillin, 25 μg/ml kanamycin/ml and 50 µg
glycine/ml an 50 µg serine/ml on BV minimal agar with 200 μg/ml ampicillin, 25 μg/ml
kanamycin/ml and 100 ng/ml tetracycline. The next day, tiny colonies started to appear on the YT
plates and within 48 hours, colonies developed. On BV minimal media, colonies started to appear
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after 48 hours. After 48 hours, six colonies from the YT plate were selected and individually
inoculated into YT broth with 200 μg/ml ampicillin. After overnight growth, the plasmid DNA
from eight colonies were purified and the identity of the insert was confirmed by DNA sequencing
with T7 and T7 terminator primers. On the BV minimal plate ~ a total of 75 colonies were detected,
suggesting the clone rescued JW2535-1to prototrophy.

Figure 3-18 Partially digested glyA-pCR2.1
The glyA-pCR 2.1 vector was fully digested with NdeI and partially digested with XhoI.
Fragments were separated on a 1% agarose gel. Lane 1(A): Uncut glyA-pCR 2.1, Lane 2(B):
NdeI digested glyA-pCR 2.1, Lanes 3 to 7: (partial digest tubes numbered 1 to 5) partially
digested glyA-pCR 2.1, and Lane 8:1 kb plus DNA ladder. Lane 1 supercoiled glyA-pCR 2.1
and Lane 2 shows the approximate size of vector plus insert, ~ 5,000 bp. Lanes 4 to 7: partially
digested glyA-pCR 2.1. The size of the top fragment was ~4,000- 5,000 bp. The next
fragment was slightly lower than the 1,500 bp marker and the bottom band was ~1,000 bp.
Since the middle fragment (black arrow) was closer to the expected glyA size of 1,254 bp, the
DNA from all five lanes was excised and used for clonin
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Assessing the growth pattern of E. coli JW2535-1 (∆glyA::kan)
After receiving E. coli JW2535-1 (∆gly::kan) from the Coli Genetic Stock Center, we
tested it for glycine and serine auxotrophy [26]. The cells were grown in YT liquid media with
added 50 µg glycine /ml, 50 µg serine /ml, and 25 μg kanamycin/ml. The overnight culture was
streaked on BV agar media supplemented with 50 µg glycine /ml, 50 µg serine /ml, and 25 μg
kanamycin/mL and/or BV minimal media with 25 µg kanamycin/ml. The plates were incubated
at 37 oC and checked for five consecutive days. After 24 hours, cell growth was observed on BV
supplemented media, but cells did not grow on BV minimal media for two days. However a slight
cell growth was observed after 96 hours. The image for 48 hours growth is shown in Figure
3-19(below). These results suggest that E. coli JW2535-1 (∆glyA::kan) is auxotrophic for glycine
and serine.

Figure 3-19 The growth pattern of E. coli JW2535-1 (ΔglyA::kan).
E. coli JW2535-1 (ΔglyA::kan) did not grow on the BV minimal media (panel B), but it did
grow on BV media supplemented with glycine and serine (panel A).

Identification of the tetracycline concentration required for sufficient in vivo SHMT
production to rescue E. coli JW2535-1 (∆glyA::kan) to prototrophy
To determine the minimum tetracycline concentration that allows confluent cell growth
of E. coli JW2535-1 carrying the glyA-pKTS plasmid, cells were grown in YT liquid media with
200 μg ampicillin/ml and 25 μg kanamycin/ml. Next the cells were plated on BV minimal media
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with 200 μg ampicillin/ml, 25 μg kanamycin/ml and various concentrations of tetracycline (10,
25, 50, 75, 100, 200 and 500 ng/ml). The plates were examined for four days. After 48 hours,
confluent cell growth was observed. Images of cell growth at 72 hours are shown in Figure 3-20
(below). Confluent growth was obtained on the plates with 10 to 100 ng tetracycline/ml, but the
cell growth became sparse on 200 and 500 ng tetracycline/ml plates.

Figure 3-20 Tetracycline dependent glyA production.
The optimal tetracycline concentration required to induce production of sufficient SHMT to
rescue E. coli JW2535-1 (ΔglyA::kan) carrying the pKTS-glyA plasmid from glycine and
serine auxotrophy was determined. Increasing concentrations of tetracycline were added to
BV minimal media containing 200 μg ampicillin/ml and 25 μg/ml kanamycin. Confluent cell
growth was achieved on plates with 10-100 ng tetracycline/ml. The bottom right panel shows
how the various cultures are streaked on the plates.
3.6

Beginning steps to clone the dihydropteroate synthase gene into the pKTS plasmid
Dihydropteroate synthase (DHPS) is encoded by the folP gene. The protein catalyzes the

formation of 7,8-dihydropteroate by linking 6-hydroxymethyl-7,8-dihydropterin pyrophosphate
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(H2PtPP) and ρ-aminobenzoic acid (pABA) [56]. If osmolytes preferentially interact with either
substrate, the catalytic efficiency of DHPS is predicted to decrease. As an initial step to test this
hypothesis, we obtained a folP-pUC19 clone and the knockout E. coli strain (folP::kan) from Dr.
Swedberg [90]. Progress was made as described below.
3.6.1 Assessing the quality of the folP clone and assessing the cloning sites in the gene
The plasmid DNA received from Dr. Swedberg was sequenced using M13 forward and
M13 reverse primers. The sequence alignment showed the folP open reading frame was cloned
between HindIII and BamHI cloning sites of pUC19. To introduce an NdeI restriction site
sequence via PCR, a primer was designed as described in the Materials and Methods section.
While the primers worked as sequencing primers, several attempts to PCR amplify the gene were
not successful.
As an alternate strategy, we decided to design a “pessimal” DNA sequence encoding folP.
As codon optimization is a frequent strategy to increase protein production, we took the opposite
approach and designed a “worst” sequence to minimize protein production. The sequence design
was done in collaboration with Mike Gilchrist from the Ecology and Evolutionary Biology
Department [91, 92]. The resulting sequence was synthesized by GenScript. The construct was
sent to us as a folP gene inserted in the pET3a plasmid using the NdeI and XhoI restriction enzyme
sites. This construct was transformed into DH5α cells. Individual colonies were selected on YT
agar media with 200 μg ampicillin/ml. Four colonies were grown up, the plasmid DNA extracted
and the DNA sequenced.
In an initial experiment, the plasmid DNA of folP-pET3a was double digested with NdeI
and XhoI. The DNAs were separated on a 1% agarose gel Figure 3-21(below). The correct sized
DNA fragments were excised. However ligation and transformation reactions did not yield
colonies. This is an ongoing project in the lab.
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Figure 3-21 NdeI and XhoI digested folP.
Digestion of folP-pET3a DNA by NdeI and XhoI. The reaction was
electrophoresed in a 1% agarose gel. Lanes 2, 3, 5 and 6: digested folP-pET3a,
Lane 8: 100 bp DNA ladders. Lanes 2, 3, 5 and 6 showed the expected DNA
fragment size (849 bp) for folP digestion by NdeI and XhoI. The arrow shows the
band of interest.
C
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HAPTER. 4:
4

Chapter 4 : Discussion

Discussion
These in vivo genetic studies were designed to test our model presented in Figure 1-5 on

page 5 that proposes osmolytes interact with folate and its various redox states. Table 1 (below)
shows our progress for 6 folate pathway enzymes. Not all enzymes were cloned and screened,
however our success with the wild type R67 DHFR clone provides a proof of concept for using
the pKTS plasmid to decrease protein expression levels so that a genetic selection can be
implemented that responds to osmotic stress. Each enzyme will be discussed briefly below.
Table 1. Summary of results for several folate metabolism enzymes.

a

not applicable.
continued by Deepika Nambiar. Deepika sees a clear osmotic stress effect for MTHFR. It is
too early to tell for SHMT.
b
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4.1.1 R67 DHFR and/or Quad4
Success in titrating the in vivo R67 DHFR activity using osmotic stress was previously
achieved using a Y69L mutant and using resistance to the EcDHFR active site directed inhibitor,
trimethoprim. In this thesis, we extend this osmotic stress titration to the wt R67 DHFR enzyme
using the controllable Ptet promoter and a SsrA tag encoded by the pKTS plasmid. To monitor
enzyme activity directly, we used a knockout strain where the folA gene was replaced by a
kanamycin resistance marker. This strain, LH18, was rescued by the pKTS-R67 DHFR or pKTSQuad4 plasmids.
The pKTS-R67 DHFR construct required an ~2.5x higher concentration of tetracycline to
provide sufficient DHFR activity to confer TMP resistance and/or rescue LH18 from folate end
product auxotrophy. The tetracycline titration images are shown in Figure 3-2 page-46 and Figure
3-4 page-49. As described in the Methods section, the ability of an enzyme to rescue the host cell
from the missing metabolic activity and/or to confer resistance to TMP is dependent on the
catalytic activity as well as the in vivo concentration of the enzyme. As R67 DHFR and Quad4
have similar catalytic efficiencies [5], this is unlikely to be the parameter involved.
The other main difference between R67 DHFR and Quad4 is their oligomerization states;
R67 being a homotetramer and Quad4 being a monomer. Therefore R67 DHFR would carry four
SsrA tags in comparison to one per Quad4. This scenario predicts the in vivo concentration of R67
DHFR will be lower than for Quad 4 as the SsrA tag targets the protein to the ClpX protease. More
tags are expected to increase targeting. This is likely the reason for the increased tetracycline
concentration required to provide TMP resistance or growth to the knockout strain for the pKTSR67 DHFR clone as compared to the pKTS-Quad4 clone.
Confluent cell growth of DH5α and LH18 carrying the pKTS-R67 DHFR and pKTSQuad4 clones was observed on the minimal plates up to 200 ng tetracycline/ml. However cell
growth became sparse at in the presence of 500 ng tetracycline/ml. This result suggested this
concentration of tetracycline was above a threshold and became toxic to DH5α and LH18. Similar
observations were reported by Neuenschwander et al. when using the green fluorescent protein
(GFP) gene cloned into pKTS and expressed in XL1-Blue and DH5α E. coli strains [88]. In XL1-Blue, GFP production was increased until a concentration of 5,000 ng tetracycline/ml was
reached. But in DH5α, GFP production was increased until 100 ng tetracycline/ml was reached;
however GFP production started to decline at higher tetracycline concentrations [88].
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Neuenschwander proposed individual strains have different tolerances to higher tetracycline
concentrations.
Under normal conditions, bacterial cells maintain turgor pressure, which is a higher internal
osmotic pressure than their surrounding environment/medium. However when the outside osmotic
pressure becomes higher than the intracellular pressure, bacteria generate their own internal
osmoprotectants and/or transport osmolytes from the environment [93]. As a result, the
cytoplasmic water concentration and growth rate decrease [94]. In 2003, Cayley and Record
showed that as the external osmotic pressure rises, the cytoplasmic free water concentration
decreases as does the cell growth rate of E. coli [17]. When no free water remains, cell growth
stops. This is the upper limit for our osmotic stress assays.
To establish a baseline to assess the activity of R67 DHFR and Quad4 rescuing DH5α
and/or LH18 from TMP resistance and/or folate end product auxotrophy, bacterial osmolality
fitness was measured by adding increasing concentrations of sorbitol to the growth media. The
media supplied all the metabolic needs of the bacteria, and bacterial fitness was identified based
on the osmolality of the plate where the bacteria stopped growing. DH5α growth was decreased
under 1.90 Osm and completely stopped at 2.43 Osm (Figure 3-5 page 51), while LH18 (Figure
3-7 page 54) growth decreased at 1.50 Osm and stopped at 2.12 Osm. Previously differences in
osmotic fitness between bacteria strains and organisms have been reported [95, 96].
When DH5

carrying pKTS-R67 DHFR (Figure 3-6 page-52) was examined, the cells

were able to grow on media containing TMP up to 1.23 Osm and the pKTS-Quad4 clone enabled
growth up to 1.60 Osm. These results showed the increased viability associated with the pKTSQuad4 clone compared to that of pKTS-R67 DHFR containing cells. In addition, E. coli LH18
(∆folA::kan) carrying pKTS-R67 DHFR and/or pKTS-Quad4 allows cell growth up to 1.37 Osm
and 1.68 Osm, respectively (Figure 3-8 page-55). These different limits indicate the Quad4 clone
provides a selective advantage. A scenario consistent with our model suggests that upon addition
of sorbitol, the E. coli cells synthesize their own osmoprotectants, including betaine [17]. As
betaine addition decreases the catalytic efficiency of R67 DHFR, the R67 DHFR activity is
titrated such that insufficient activity remains to allow cell growth. This titration is seen in vitro
in Figure 1-4, page 4. Other osmolytes and crowding molecules may be present in the cell and
their potential effects add complicating layers to the analysis. Cayley and Record find that
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betaine is the predominant osmoprotectant in E. coli grown in a minimal MOPS media with
added 1mM betaine [17]. A future experiment will test the effect of this media on our titrations.
When we compare the in vivo osmotic stress titrations of R67 DHFR and Quad4 activities,
we find the Quad4 clone confers a growth advantage. Both enzymes have similar protein scaffolds
and enzyme activities; however the pKTS-Quad4 construct likely allows a higher cytoplasmic
protein concentration as it possesses fewer SsrA tags. Quad4 may be considered to be an internal
control for R67 DHFR as a higher Quad4 protein concentration leads to growth at higher sorbitol
concentrations. This comparison supports our contention that sorbitol addition results in higher
osmoprotectant concentrations inside the cell, which then decreases the catalytic efficiency of R67
DHFR such that it can longer support cell growth.
Several other experiments can be explored to test our hypothesis. For example, if R67
DHFR concentration is the important variable, we can perform a tetracycline titration at sorbitol
concentrations that block cell growth. For example, LH18 carrying pKTS-R67 DHFR stops
growing at 1.00 M sorbitol (= 1.60 osmolality) in the presence of 100 ng tetracycline/ml. We can
vary the tetracycline concentration so that more or less R67 DHFR is produced and monitor the
effect on cell growth. We would predict that addition of a higher tetracycline concentration would
allow growth at this osmolality.
A third issue considers whether osmotic stress is the variable that blocks cell growth. For
example, sorbitol can be used as a carbon source by E. coli [97], thus we propose to additionally
use NaCl as an osmotic stressor. Preliminary studies by Noelle Lebow, a summer REU student,
indicate NaCl addition can block the growth of LH18 carrying pKTS-R67 DHFR on minimal
media at osmolalities lower than the upper limit (i.e. where no free water remains). As NaCl
contains 2 ions which contribute to the solution osmolality, cell growth stops at media containing
0.75 M NaCl. Further the measured osmolalities of the agar compare to those measured in sorbitol
containing media. These preliminary experiments are consistent with osmotic stress induced by
either sorbitol or NaCl resulting in intracellular titration of R67 DHFR activity such that E. coli
growth is no longer supported.
4.1.2 Folypolyglutamate Synthase (FPGS)
E. coli: SF2 (folC strA) [50] has a leaky mutation at A309T that decreases the catalytic
activity to 1-3% of wild-type FPGS levels and the total folate pool drops to 10 to 30 % of normal
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in vivo concentration. SF2 is auxotrophic for methionine. For this strain to grow in minimal media,
methionine is required. Addition of glycine further stimulates growth. The KMs’ of A309T, FolC
are much higher compared to the wild type [98]. Because the in vivo activity of the mutant is low,
it seemed feasible to assess the effects of increasing osmolality directly on the chromosomal
enzyme on supplemented media. In other words, the low turnover rate of the enzyme would allow
in vivo selection [22]. If osmolytes weakly interact with dihydropteroate and/or tetrahydrofolate
based substrates, this could further weaken their binding to FPGS and potentially titrate the activity
of the mutant enzyme. Since loss of FPGS activity is lethal to the cell, this could block cell growth.
Variable cell growth patterns are one of the main challenges of assessing in vivo assays
for several unknown factors. To provide a control, we plated SF2 and its parent strain MG1485
with and without a plasmid containing the wild type FolC clone. We assumed the SF2 carrying
clone and the parent strain would have similar cell growth patterns. However, as seen in
Figure 3-10: page 57, growth of SF2 and SF2 carrying a functional clone decreased on a 1.00 M
sorbitol plate and stopped on a 1.25 M sorbitol plate. However, the parent strain (wt) and parent
strain carrying the pPM103-FPGS plasmid stopped growing in 1.50 M sorbitol, while the parent
strain carrying pAC5 stopped in growing in 1.25 M sorbitol containing media. One possibility
for the decreased growth of both the parent and SF2 strains containing plasmid could be the loss
of the plasmid. In an attempt to retain the plasmid by increasing the metabolic selection pressure,
the methionine concentration was decreased to a minimal level while the glycine concentration
remained in excess. As shown in (Figure 3-11 page-59) increasing the metabolic selection
pressure did not resolve the problem.
Several explanations were considered for the inability of cloned FolC genes to rescue SF2
under high osmotic pressure. First, we asked whether the A309T mutation could be dominant
negative mutation over the wt gene. When considering models of dominant negative action, a
mutation can lead to an oligomer containing wild type and mutant polypeptides, which has greatly
diminished activity [99]. This scenario seems unlikely as FPGS is a monomer. Indeed, a truncated
FPGS gene was found not to be dominant negative over wt FPGS in a human blood cell line [100].
A second explanation might be that the polyglutamylation state of folates in the cell could
impact the function of folate mediated 1C metabolism enzymes. For example, with low -FPGS
activity, most folates may be mono- to tri-glutamylated on the -carboxylate. After this, an FPGS adds glutamates at the -carboxylate. With a higher -FPGS activity, longer 77

polyglutamylated folates may be made which could affect the sensitivity of the cell to osmotic
stress.
In a third and more likely alternative, we speculate that the ethylmethane sulfonate (EMS)
mutagenesis [49] procedure that was carried out on MG1655 to generate the folC mutant could
have created an additional mutation(s) that impacts cell growth under osmotic stress. For example,
if SF2 contained additional mutations in stress response and/or osmotic stress response gene(s),
the loss of this function could be manifested in our assay conditions.
To pursue the effect of osmotic stress on FPGS in the future, we have several avenues.
One is to use the folC::kan knockout of Pyne et al. [69], which is based on the SF2 strain. Since
Pyne et al. [69] could only delete the chromosomal FolC gene when a plasmid FolC gene was
present in trans, several FPGS mutants at residue A309 were used with progressively decreasing
activities. For example, the A309V, A309I, A309G, A309V, A309R, A309E and L A309L
mutants have progressively weaker activities[50] and require progressively more folate end
products to be added to the media to allow growth. While we requested and received several of
these strains, they did not grow up. The Bognar lab also had difficulty in retrieving them from
their freezer stocks. We can try re-requesting them.
We also have the option of requesting the knockout strain constructed by Pyne et al. [69]
that has the C600 E. coli background. This strain carries a pPMpac3a plasmid that can be
segregated or cured once transformed with another plasmid carrying the FolC gene. We would
clone either the wt or a mutant FPGS gene into pKTS and transform this folC::kan strain with it.
We could cure the strain of the pPMpac3a plasmid by growth at 37-42oC. We could then re-try
the sorbitol titration.
4.1.3 5,10-Methylenetetrahydrofolate Reductase (MTHFR)
Our initial literature review indicated the KM of MTHFR for its substrate, 5,10-methyleneTHFn , is ~30X [36] less than the in vivo concentration of this molecule [34, 51]. As shown in
Table 1, the gene was cloned into pKTS and the tetracycline concentration to rescue a knockout
cell from methionine auxotrophy was determined. The system was set up and Deepika Nambiar
joined the lab and is continuing to assay the sensitivity of the metF system to osmotic stress. She
finds blockage of growth of metF::kan cells carrying the metF-pKTS clone on minimal media
containing lower concentration of sorbitol, while the metF::kan cells continue to grow in
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supplemented media containing higer concentration of sorbitol. These results suggest as the
intracellular osmolality of the cell increases, the activity of MTHFR decreases and is no longer
able to rescue the host cells from methionine auxotrophy. Considering our model showing the
preferential interaction of osmolytes weaken DHF binding with the enzyme Figure 1-5 page 5, if
the host cell generates betaine [17], and betaine preferentially interacts with 5,10-methylene-THFn,
the ability of MTHFR to provide the missing metabolite should decrease with increasing osmotic
pressure. Overgrowing colonies occur in these titrations (but still stop growing at low
concentrations of sorbitol), so additional experiments still need to be performed to identify the
suppressor mutation(s). One possibility is the loss or mutation of the SsrA tag.
4.1.4 Serine Hydroxymethyl Transferase (SHMT)
As shown in Figure 3-19 page-69 the tetracycline dependent growth of E. coli JW25351 (ΔglyA::kan) carrying the pKTS-glyA showed protein production-dependent cell growth that can
be illustrated in Figure 1-7page 10. A study on the effects of increasing osmolality on the function
of GlyA is in progress by Deepika Nambiar.

4.2

Conclusion
This thesis describes the in vivo genetic complementation assays that show an effect of

increasing osmolality on the function of essential folate enzymes. This study is expanded from in
vitro studies that showed prefere ntial interaction of osmolytes with DHF/folate, which weakens
binding and lowers the catalytic efficiencies of th ree structurally different dihydrofolate reductase
enzymes [2, 3, 23]. Our in vivo results for R67 DHFR and Quad4 established a proof of concept
that our in vivo assay conditions mimic our in vitro results, as we can titrate the activity of targeted
folate enzymes in vivo. DHFR activity could be titrated out by the addition of external osmolytes,
frustrating the growth of the cell. Additionally, in vivo assays are in progress for three other folate
enzymes: MTHFR, SHMT and DHPS. If successful, the results of these assays, could suggest
generalization of our model of osmolyte interaction with DHF to include THF redox states.
Moreover, unintended consequences of the folate-osmolyte interactions on other folate cycle
and/or cellular networks are in progress using a metabolomics approach.
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4.3

Future experiments
Preferential interaction of DHF/folate with osmolytes is a unique event that has been

detected by the Howell lab. This environmental parameter can be measured by in vitro as well as
in vivo experiments. Our in vivo studies are at an initial stage. While solid media is useful for
broader assessments of the effects of osmolytes on cell growth, liquid media can provide an
alternative to determine the growth rate, which can be correlated with in vitro enzyme parameters.
For example, Caley et al. [17] showed adding 1 mM betaine to a growth media stimulated and
determined the rate of production/accumulation and types of intracellular osmolytes. It will be
interesting to assess the effects of different solute/osmolyte addition in the variations of internal
osmolality and its effects on the activity of the folate enzyme in vivo.
If this approach with other wt enzymes does not work, one possibility is that the enzyme
activity remains sufficiently high so that it is refractive to sorbitol titration. To decrease the total
enzyme activity in the cell, we can mutagenize active site residues. For example, if we are unable
to titrate DHPS activity, we can construct the N27A mutation, which decreases enzyme activity
77 fold [101].
We recognize that the cell is a complicated environment. Thus another reason for loss of
growth in our in-cell osmotic stress assays would be a decrease in the DHFR concentration under
high osmolality conditions. Future experiments will monitor the effect of osmotic pressure on the
total DHFR concentration using an ELISA assay or a Western. However we note that in one
osmotic stress response study, most E. coli proteins were found to show similar expression levels
(within a 2 fold window) [102].
A second complicating factor may be that other folate pathway enzymes could also be
affected. For example, when EcDHFR activity is inhibited by TMP addition, Kwon et al. found
the DHF concentration rises [36]. This in turn inhibits the activity of FPGS. Kwon et al. term this
a “domino effect” in that several consecutive events can occur, which can amplify the initial effect.
To consider this scenario, we propose to perform folate metabolomics with Shawn Campagna in
the chemistry department to monitor the concentrations of many folate metabolites. This will
allow us to identify any additional inhibitory effects by monitoring whether the metabolite
concentrations fall or rise. Use of metabolomics will also allow us to monitor the concentrations
of E. coli osmoprotectants.
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An additional complication considers the preferential interaction coefficient (µ23/RT)
predictions given in Table 1.1. page 9. Elongation of the polyglutamate tails of folate and its redox
states allows retention of folates in eukaryotic cells by the presence of additional negative charges,
which decreases ligand efflux out of the cell. In prokaryotic cells, polyglutamylation is proposed
to be important for binding to certain enzymes, for example binding of methylene-THF to the nonB12-dependent methionine synthase [49]. The calculated µ23/RT values in Table 1.1 predict the
overall exclusion of osmolytes from the polyglutamylated folate species, which would lead to the
prediction of tighter binding of the polyglutamylated folates in the presence of osmolytes.
However, if the polyglutamylated tail is not used in binding and does not need to be desolvated,
then removal of osmolytes from the pterin and pABA rings could dominate and lead to weaker
binding. We are addressing this issue for one specific case by performing ITC studies of PG5
(folate with 5 glutamates) binding to R67 DHFR. PG5 shows the same Kd as for folate [103],
suggesting the additional 4 glutamates in the tail are not in contact with the enzyme binding pocket.
If water and/or osmolytes do not need to be removed for the ligand to bind, then they will not
contribute to the experimental µ23/RT value; thus the experimental and calculated µ23/RT values
may differ depending on the extent of the ligand contact with the active site. To do this for other
folate pathway enzymes, we would need to do further in vitro studies.
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